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frameworks 
 
Abstract  
Objectives:  Screening for breast, cervical and colorectal cancer in an average-risk population is 
widely recommended in national and international guidelines although their implementation varies. 
Using a conceptual framework that draws on implementation and health systems research, we 
provide an overview of systematic literature reviews that address health system and service barriers 
or facilitators to effective cancer screening.  
Methods:  Using a systematic approach, we searched Cochrane Database of Systematic Reviews, 
Ovid Medline, Ovid Embase, Web of Science, PsychInfo and other internet sources. We included 
systematic reviews of screening interventions (i.e. targeting people at average risk) for breast, 
cervical and colorectal cancer. The analysis included 90 systematic reviews.  
Results: This review identified a multitude of barriers and facilitators affecting the health system, the 
capabilities of individuals in the system and their intentions. A large proportion of the available 
evidence focused on uptake. The reviews demonstrated that health system factors influenced 
participation, as well as quality and effectiveness of the service provided. The barriers with the 
biggest impact were knowledge/education, mainly of clients but also providers (capability barriers) 
and beliefs and values (intention barriers) of the eligible population. These findings complement the 
usual focus on psychological and social barriers to informed participation by individuals that 
dominate the screening literature. The facilitators with the most supporting evidence were 
educational interventions (overcoming capability and intention barriers), invitation letters and 
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reminders and appointments. These were mainly directed at eligible individuals and, to a lesser 
extent, to providers and healthcare professionals. Only a small number of reviews, mainly from 
Europe, specified organised, rather than opportunistic, screening programmes. In those, low 
participation was the most frequently cited barrier and invitation letters (including physician 
endorsement, phone calls, and reminders to non-responders and healthcare professionals) were the 
most prevalent facilitators.  
Conclusion: Despite evidence of barriers and facilitators to screening participation and opportunistic 
screening, further health systems research covering the entire screening system for organised 
programmes is required. 
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Introduction  
 
The European Union recommends population-based screening programmes for breast, cervical and 
colorectal cancer(1), while various guidelines set out how to implement such programmes(2-6). 
However, implementation varies greatly(7) and many programmes fall short of the ideal(8, 9). While 
much research examines the characteristics of individuals undergoing screening, there is, to our 
knowledge, much less focus on the characteristics of health systems that support or inhibit effective 
screening programmes.  
In this article we report the findings from an umbrella review of existing systematic reviews seeking 
to identify barriers and facilitators to population-based screening that are related to characteristics 
of health systems. We use the World Health Organisation’s (WHO) definition of health systems as 
consisting of ‘all organizations, people and actions whose primary intent is to promote, restore or 
maintain health’ (10). Firstly, we identify barriers that have been reported in the literature and, 
where possible, assess their impact.  Secondly, we identify measures that have been suggested to 
overcome these barriers and, where possible, assess their effectiveness.  Thirdly, we seek to 
understand the influence that these barriers and facilitators have on organised screening 
programmes. We use frameworks(11) that  draw on theories from behaviour change(12) and 
implementation research,(13) including those used by Michie et al.(14) who propose 12 subthemes 
for investigating implementation of evidence-based practice, organized within three main themes. 
Health system barriers include availability of resources, affordability, and acceptability of health 
services. Capability barriers relate to knowledge or skills to implement effective screening 
programmes. Intention barriers relate to motivations of providers to achieve effective screening. 
When looking at health systems barriers we draw on two related frameworks. The first was used in 
previous systematic reviews of barriers and facilitators to effective hypertension management(11, 
4 
 
15) and considers the contribution of health system inputs, including physical, human, intellectual 
and social resources, on outcomes. The second is the WHO’s health systems building blocks, with 
service delivery, the health workforce, health information systems, leadership and governance, and 
financing most relevant to screening(16). However, in practice, many of the barriers we identify 
involve a combination of elements, for example where locations are underserved by facilities, it 
reflects both weaknesses in service delivery and inability to recruit and retain staff. 
Objectives 
 
We reviewed systematic literature reviews that identify, explore and evaluate barriers and 
facilitators to establishing effective cancer screening programmes at health system and health 
service level. We sought to identify gaps and make recommendations for future research. Individual 
cultural, psychological and social obstacles to informed participation lay outside the scope of this 
review. 
Methods 
 
A protocol was registered ‘a priori’ on PROSPERO, the international prospective register of 
systematic reviews(17).  
Search strategy and selection 
 
We searched for relevant systematic reviews in the following databases: Cochrane Database of 
Systematic Reviews; Ovid Medline; Ovid Embase; Web of Science; PsychInfo; and Google Scholar. 
We reviewed project websites (for example, Evidence for Policy and Practice Information Centre; 
Health Systems Evidence; Health Evidence Network; Agency for Healthcare Research and Quality) 
and contacted experts participating in the EU-TOPIA (TOwards imProved screening for breast, 
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cervical and colorectal cancer In All of Europe) project(18), of which this research forms a part, to 
identify relevant grey literature. Reference lists of publications retrieved were manually searched. 
Selected databases were searched from 1st January 2000 to 9th June 2017 using relevant search 
terms (Appendix 1, online supplement).  Two reviewers independently assessed the titles and 
abstracts of the identified publications according to pre-defined inclusion criteria (Appendix 2, online 
supplement) and differences were resolved by discussion.  
Data collection and analysis 
 
Data from included systematic reviews were extracted using a predefined data extraction sheet. 
Fields included: authors; year of publication; objectives; selection criteria; information about barriers 
and facilitators; and impact on the effectiveness of screening. Authors were contacted where full 
texts were not available (only one responded). Data were extracted by one reviewer and checked by 
a second reviewer who extracted data on study design and applied the AMSTAR (A MeaSurement 
Tool to Assess systematic Reviews). Reviews were not excluded from data extraction on grounds of 
quality.  
A narrative synthesis using the conceptual framework (Figure 1) was conducted. The heterogeneous 
nature of the included data precluded quantitative synthesis or formal assessment of publication 
bias. We collated the data for all cancer sites together but noted where items were relevant to only 
one cancer site. We analysed differences between organised screening programmes and other 
screening interventions.  
 
Results 
Study characteristics and quality 
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From 536 identified titles, 90 articles were included in the review (Figure 2). As summarised in Table 
1, of the 90 included articles, 75 were in English and 15 had abstracts available in English. A summary 
of the characteristics of the included systematic reviews is presented in Appendix 3 (online 
supplement) and a list of excluded reviews is reported in Appendix 4 (online supplement). A 
summary of the quality of the included systematic reviews, assessed using the AMSTAR instrument, 
is presented in supporting information Appendix 5 (online supplement). Whilst generally of good 
quality, included reviews used slightly different reporting criteria to those in the AMSTAR checklist, 
for quantitative meta-analysis studies and controlled trials.  
Drawing on the first conceptual framework, as shown in Figure 3, we found that whilst health system 
resources, financing and delivery were mentioned in some included systematic reviews, the vast 
majority were interested in ‘other factors’ that acted as barriers or facilitators to screening, most 
notably the target population’s health knowledge, the effectiveness of appointment reminders, 
personal and cultural beliefs, and physician recommendations.  
In the following sections, the second framework allows us to describe the barriers and ways to 
overcome those barriers in more detail using the health system, capability and intention categories, 
and their sub-categories, described in Figure 4. 
Barriers to effective screening 
 
Health system barriers 
 
Much of the literature addresses barriers that reduce uptake of screening. These can be 
geographical, temporal, procedural, financial, or related to perceived quality.  
Geographical barriers to services and facilities are especially important, but not exclusively so, for 
those in remote areas. Screening facilities were sometimes in inconvenient locations(A1-A3), 
involving long travel distances(A2-A4), and posing transportation difficulties(A1, A2, A5-A8). 
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Temporal barriers include inconvenient appointment times(A2, A5, A9), long waits before 
appointments were available(A1, A5), unsuitable appointment times(A3, A10), and waiting room 
delays(A5, A11). Delay in receiving results may reduce participation in subsequent screening or 
intervention rounds (A5, A12). Procedural barriers relate to problems sending screening 
invitations(A1, A2), limited access to primary care(A11, A13), and a variety of organisational 
barriers(A4, A10, A13-A15) including cumbersome administrative processes(A12,A16). Financial 
barriers featured in many systematic reviews, especially where many in the target population lacked 
health insurance or other forms of coverage(A6, A9, A11, A13, A17-A20) or among those whose 
insurance excludes coverage of screening(A1, A2, A6, A7, A11, A13, A14, A17, A21, A22). Some 
reviews also identified financial constraints affecting providers(A4, A11, A13, A23, A24), including 
the cost of screening tests(A1, A2, A7, A9, A11, A15), which have implications for the ability to 
deliver services – for example where constraints affect the ability to recruit and retain staff.  
Perceptions of quality also matter(A1, A25), indicated by objective measures of screening test 
performance(A1) or subjective patient experiences(A1, A3, A25).  
Only two reviews considered inappropriate screening due to overuse(A26, A27), which is most often 
associated with opportunistic screening, although several reviews did highlight features of health 
systems that made it difficult to implement organised population-based screening programmes in 
place of opportunistic screening (A18, A28-A31). 
In general, these reviews did not take a health systems perspective – in other words, they did not 
seek explanations for the reported barriers in the design of the health systems in which they were 
embedded. However, the findings do suggest weaknesses in relation to all the inputs to health 
systems and their building blocks, in particular leadership and governance, but also service delivery, 
workforce, and information systems.  
Capability barriers 
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Only a few reviews examined the knowledge of health care providers(A11, A13, A32). Instead, most 
of the available evidence related to the capability of those being screened, with many studies 
identifying lack of awareness of either the rationale for screening or how to be screened(A2, A4, A8, 
A9, A11, A13, A15, A17, A27, A32-35).  
 
Intention barriers  
 
Multiple reviews identified a failure by providers to recommend screening(A2, A4, A8, A9, A11-13, 
A17, A19). Some described this as negligence(A32), while others attributed it to a lack of awareness 
of the need for screening(A1, A2), particularly for older adults, suggesting an implicit ageism(A21). 
Several pointed to inadequate communication between clinicians, providers and eligible 
individuals(A4, A11, A15, A18) but also, and arguably of greater concern, the spread of 
misinformation among the lay public(A1). These findings, and those relating to capabilities, point to 
weaknesses in leadership and governance, in particular poor recognition of the need to understand 
public knowledge and perceptions and to put in place measures to address knowledge gaps and 
misconceptions. 
Whilst this umbrella review explicitly excluded non-health system barriers specific to individuals or 
particular subgroups and cultures – for example barriers related to knowledge, attitudes and 
practices among a target population –   it was notable that these issues dominated many of the 
included reviews. These factors affecting informed participation, or intention to participate, are 
therefore summarised in the online supplementary information (Appendix 6). These factors also 
have implications for the leadership and governance of health systems, highlighting the requirement 
to put in place systems to identify unmet need and facilitate equitable uptake.  
The impact of health system barriers versus other barriers 
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Assessing the impact of barriers was challenging as most of the included systematic reviews 
reporting barriers (24 of 36 reviews) included studies using a variety of methods, not all of which 
could quantify impact. Those that focused on particular study designs included qualitative (4 
reviews), observational (1 review), quantitative (3 reviews), and interventional studies (including 
randomised controlled trials (RCT) and comparative studies) (4 reviews). Hence, quantitative 
syntheses evaluating the impact of barriers were limited. Only the review of observational studies 
calculated effect sizes for different factors affecting compliance(A32).  
Of the seven reviews including quantitative and interventional studies, only one described the most 
frequently cited barriers,(A21) while another counted the number of studies showing significant 
association between specific factors and screening uptake(A36).   
Ten of the reviews that included mixed study designs reported the number identifying each barrier, 
a very indirect measure of importance. Otherwise, the importance of barriers can only be inferred 
from the narrative syntheses of results of included studies and author conclusions (see 
Supplementary Information).  
Once again, most of the reviews focused on the consequences of weaknesses in screening 
programmes rather than causes related to the health system. Thus, many reviews sought  to 
understand and provide reasons for non-participation, including in specific population groups 
(Korean Americans, Hmong Americans, African Americans, Arabic women, Latinas) or in particular 
countries (Asia, Africa). In general, the barriers identified as most important in the narrative reviews 
reflect those with most supporting evidence (Figure 3), with most attention paid to characteristics of 
the target population rather than the system itself. Thus, the most important barriers identified 
were knowledge/education (capability barriers), and beliefs and values (intention barriers) of the 
population. Next in importance were financing/access barriers, including characteristics of the 
health workforce (training and knowledge). Service delivery barriers (infrastructure and supplies) 
were cited to a lesser extent.  
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These findings point to a failure of much of the literature on screening to look upstream at the 
health system characteristics that contribute to uptake by the target population or to use a health 
systems frameworks to analyse or interpret findings.  
Ways to overcome barriers 
 
Health system facilitators 
 
Some of the most frequently cited interventions evaluated as means to overcome health system 
barriers involved specific practical measures rather than wider changes to health systems (such 
wider changes might include new financing models, professional roles, or settings for service 
delivery). Thus, many examined measures to improve screening invitations(A37-A39), with the aim 
of increasing uptake(A1, A2, A5, A9). Examples included having letters(A37-A39) endorsed by a 
physician(A7, A40-A42), personalised(A7, A43), accompanied by a phone call(A37), or linked to 
special events promoting screening(A44). In addition, reminder letters and follow-up phone calls to 
those invited(A10, A16, A18, A23, A28, A30, A37, A40-A42, A45-A49) and reminders to 
physicians(A40, A47, A50-A53) were also frequently mentioned as facilitators. These reminders 
could be computer-generated(A50), part of a recall system(A16), chart-based(A53), or paper-based 
(requiring responses)(A50).  
Some interventions that did take a health system approach addressed the service delivery building 
block. Examples included: seeking to reduce geographic barriers to screening (including reducing 
distance needed to travel and increasing the number of facilities per person or in an area)(A54); 
providing assistance with transportation(A7, A10, A55) or free transport(A42); organising clinic-
based outreach services to deliver screening nearer areas with low participation(A56); offering 
alternative screening sites(A10); or introducing mobile screening units(A57, A58). Other aspects of 
service delivery examined included procedures. Improvements in this regard included having 
11 
 
scheduled appointment times (as opposed to open appointments, where the onus is on the recipient 
of the invitation to make their own appointment)(A41), flexible appointment times (for example, 
offering an option to change to out-of-hours or to meet individual needs)(A12, A46), more 
convenient out-of-hours appointments(A10), measures to decrease waiting times(A1, A25) and 
assistance for individuals to help schedule appointments(A45, A55, A58).  
A few interventions addressed the health workforce, for example, employing staff of the same 
gender or minority group(A3-A5, A20). Others transferred roles to the person being screened, for 
example with self-sampling by post(A31, A40, A41, A48, A59-A61) where technically possible (for 
example, colon and cervical self-sampling). 
Two interventions addressed health system financing, in terms of increasing insurance 
coverage(A17, A55). However, most that sought to overcome financial barriers looked at more 
targeted approaches,(A16, A32, A53, A62) including providing monetary incentives(A10, A30) or 
vouchers, or otherwise reducing out-of-pocket costs(A1, A7, A10, A47, A48, A57). 
Human resource strategies featured in a few reviews, including task shifting, using nurse 
specialists(A10, A12, A30, A47, A49, A63, A64), screening in the community setting (lay or outreach 
workers)(A28, A42, A49, A56, A58, A65) and involving primary care workers (A8, A39, A43, A45, 
A51). The concepts of ‘patient navigation’(A29, A42, A45, A52, A55) and aiding patients to make 
informed decisions(A84-A86) were evaluated in several reviews.  
Capability facilitators 
 
Some studies considered methods for facilitating improvement in provider capabilities. Ways of 
overcoming knowledge and skill barriers among providers included cascading of guidelines(A69), 
education and training(A31, A58), and measures to increase the extent to which providers 
recommend screening(A8, A24, A32, A42, A70, A71). A few studies examined measures to enhance 
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the quality of screening, including improved training of those conducting screening tests(A1, A10, 
A12, A25), double reading of samples(A72, A73), audit and feedback(A47). 
However, most reviews focused on measures to improve uptake by those in target populations(A29, 
A56, A74), such as: one-to-one education(A10, A16, A23, A42, A48); mailed educational 
material(A18, A31, A37, A42); face-to-face or phone communication(A29, A31, A33, A52, A66, A74-
A76); counselling(A18, A31, A38, A42, A63, A66, A67, A75-A77); education delivered by lay health 
workers(A31, A42, A57, A75, A76); multi-media information(A47, A66, A67, A76); print material(A67, 
A76); in-clinic education(A31); audio education materials (A67); personalised materials(A7, A29, 
A33); tailored information(A66, A76); small group education(A10, A16, A42, A48, A77); community-
based education(A28, A58, A66); education delivered by media(A28, A42); targeted media(A10, A16, 
A23, A77); and mass media(A10, A16, A56).  
Intention facilitators 
 
Measures to motivate providers inevitably addressed the health workforce building block. Examples 
included improving communication between primary care and other care providers(A5) and better 
mechanisms to enable coordination among clinicians, public health, cultural and religious 
organisations, advocacy and community groups(A78). As one study noted, the time and cost 
constraints involved in such measures need to be recognised(A32).  
Again, however, most measures to improve motivation were focused on the target populations, 
including the linguistic(A45, A55), cultural(A47, A49, A53, A55, A58, A1, A12), socioeconomic(A62), 
cognitive(A49) and other characteristics(A33, A53 , A62) of individuals.  
Effectiveness of interventions to overcome barriers 
 
13 
 
The systematic reviews reporting facilitators included studies with a range of methodologies but  
few summarised quantitative data or sought to establish causality. Forty one reviews provided some 
kind of synthesis, of which 14 presented the number of studies reporting a positive effect. The lack 
of standardisation across the reviews – regarding the interventions tested, reported outcomes, 
different characteristics of the target populations, and differences in the health care organization  – 
limited the synthesis of results. There is also likely to be overlap between the reviews of similar 
interventions, even though each of the systematic reviews analysed and reported the results 
differently. Some reviews reported factors positively influencing screening uptake without 
measuring effectiveness(A4, A36, A55, A78, A79). 
As shown in Figure 3, much of the available evidence (focusing on systematic reviews that provide a 
collated summary of results rather than a report of individual studies) measuring impact on 
effectiveness relates to one of three measures, each directed at individuals in the target 
populations. These are educational interventions (overcoming capability and intention barriers)(A23, 
A29, A30, A36-A38, A44, A45, A48, A49, A56, A57, A66-A68, A74, A80-A83), invitation letters and 
reminders(A16, A18, A23, A29, A30, A36-A41, A43, A48, A49, A80, A81) (to a lesser extent, to 
providers and healthcare professionals(A36, A50, A51)) and measures to improve access to 
appointments (enabling access to the health system)(A41).  
The evidence is generally supportive of educational measures(A8, A29, A30, A38, A52), particularly 
of education delivered via one-to-one sessions(A18, A23, A29, A48, A74, A81), peers, lay health 
workers(A49, A56, A57) or community interventions(A56, A65, A66, A84), telephone(A29, A36, A66, 
A74), decision aids(A52, A67, A68, A83), small media(A16, A23, A81), and mail(A37, A60, A66), 
although there are some other areas that require further investigation(A8, A36, A38). Multi-faceted 
interventions also found support(A29, A49, A57, A80). There is less evidence (either single reviews or 
mixed results) to support multi-media(A36, A66), mass media(A74, A81), special events(A44), 
mailed/printed materials(A36, A74), patient navigation(A45), personalised risk communication(A36, 
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A82) or stage-based promotion(A85), home visits(A36), tailored(A29) and group education(A48, 
A81). 
The evidence is positively supportive of invitation letters(A36-A39), including those with general 
practitioner involvement(A39, A41)(except cervical(A40) or multiple screening examinations(A37)) 
and/or personalised letters(A43) or telephone invitation(A36, A37), client reminders(A16, A18, A23, 
A30, A36, A37, A40, A41, A48, A49, A81), telephone reminders(A40, A41, A49) and physician 
reminders(A36, A40, A50, A51). Scheduled appointments(A36, A41) and self-sampling/mailed 
outreach are effective(A40, A41, A59, A60, A86). In contrast, there was a paucity of evidence on 
measures to overcome structural health system barriers, such as removal of financial, geographical, 
or other barriers.  
Organised cancer screening programmes and other arrangements 
 
The inclusion criteria accepted any systematic reviews that included population-based screening in 
the population at average risk and did not differentiate between organised programmes (where 
invitations are dispatched to all those eligible, with uptake and outcomes monitored at a national or 
regional level) and other approaches, such as opportunistic screening or screening at regular health 
check-ups. However, these approaches are quite different in their mode of operation and 
effectiveness. In general, population-based organised programmes are more effective than 
opportunistic screening in obtaining higher uptake(A39, A41) and in reducing disparities in the 
access to screening(A39). Thus, we examined the extent to which they are differentiated in the 
reviews.  
Of the 90 included systematic reviews, the vast majority did not define ‘screening’ in terms of 
organised versus other screening arrangements. Only two reviews, from Italy and the UK, specified 
‘organised’ screening programmes(A3, A41). The word ‘programme’ was interpreted in various 
ways. Systematic reviews by authors from Europe tend to use it in the sense of organised 
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programmes(A36, A39, A72), although it was not always clearly defined(A38), using terms such as 
‘community’(A37, A38) ‘average risk’(A22) or ‘mass screening’(A40, A51). The type of programme 
was also not specified in an Australian review(A4). In the USA, programmes include community-
based interventions to promote uptake of screening(A56, A58, A66).  
 
Discussion 
Summary of evidence 
 
This review identified numerous barriers and facilitators to effective screening for breast, cervical 
and colorectal cancer. The literature shows that all three cancer sites have been the subject of 
studies, with no one category particularly dominating. More systematic reviews examined 
facilitators than barriers. The overall quality of the included systematic reviews was good although it 
was difficult to fully assess quality using the AMSTAR scoring mechanism given the broad range of 
review types included, particularly qualitative reviews. 
Although we were interested primarily in characteristics of health systems that impeded or 
facilitated effective screening programmes, and particularly things that could be done to improve 
the situation, it soon became clear that the literature is dominated by research on the decision by 
individuals to undergo screening. Barriers associated with characteristics of the health system were 
frequently cited, including geographical, temporal, and informational barriers. However, responses 
were largely confined to specific interventions to deal with particular problems, with little attention 
paid to health system changes that might overcome them. Such changes might include, for example, 
new ways of paying for services, reducing costs on the individual or even paying them to attend, as 
with conditional cash transfers, or new approaches to professional regulation that might support 
task shifting.  
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The majority of evidence was from the USA, where there are few organised population-based 
screening programmes, unlike in many European countries. Instead, target groups in the USA are 
mainly defined in terms of membership of a specific health insurance plan or the lack of insurance 
coverage. There was very little evidence on how health systems might promote equitable access to 
screening. We do know that organised, rather than opportunistic screening programmes are more 
effective in this respect(19, 20), but it is important to consider not just the screening process but the 
entire pathway from invitation to eventual treatment, if needed(21). Importantly, few systematic 
reviews differentiated studies undertaken within organised and opportunistic screening activities, 
although as one review has noted, even when differentiated, there is often a lack of clarity about the 
meaning of the term ‘organised’ in the context of cancer screening(22). 
Limitations 
 
This review is potentially subject to English language and other publication bias. Whilst quality and 
reporting standards were generally good, some information was missing, particularly for conference 
posters and presentations. Moreover, reporting styles varied among reviews. The scope of this 
review did not include consideration of the impact of personal or cultural beliefs. These are 
important factors that need to be explored in depth using appropriate psychological or sociological 
methods. Due to the heterogeneous and qualitative nature of much of the included evidence, 
quantitative synthesis and statistical testing was not feasible. There is insufficient space within this 
paper to fully evaluate the effectiveness of each of the interventions included in the systematic 
reviews, given the large number and diversity of studies, populations, interventions and outcomes 
evaluated. This overview did not consider the impact on equity of access or cost effectiveness of 
facilitators to screening, although his would be important in considering the sustainability of 
interventions to improve screening(20).  
Implications 
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While the present review brings together evidence on barriers to effective screening programmes, 
there is a need for much more research on the complementary activities required to maximise 
health gain, including how to ensure that the appropriate people are invited for screening, how to 
reduce opportunistic screening, and how to improve follow-up and monitoring of people once they 
have been screened.  
Conclusion  
 
Whilst many systematic reviews have been conducted on the topic of barriers and facilitators to 
cancer screening, much of the evidence is focused on the USA and on individual participation. There 
is a need for further research into barriers and facilitators from a health systems perspective, all 
along the pathway from offering screening through to follow-up interventions for those that need 
them.  
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Appendix 1 – Database search strategy and results 
Ovid Search (including Medline, Embase and PsychInfo) until June 2017 
1 exp cancer/ 4841186 
2 cancer.mp.  4003103 
3 1 or 2 6697796 
4 (colorectal or cervical or breast).mp.  1787701 
5 3 and 4 1267418 
6 exp screening/ 705161 
7 screening.mp.  1322992 
8 6 or 7 1339427 
9 5 and 8 143254 
10 systematic review.mp.  275873 
11 systematic literature review.mp.  16060 
12 Cochrane review.mp.  6414 
13 10 or 11 or 12 287676 
14 9 and 13 2139 
15 (barrier$ or obstacl$ or hurdle$ or challenge$ or gap$).tw. 2042291 
16 exp health services research/ 180946 
17 (health$ service$ or health care service$).tw. 264437 
18 exp health policy/ 265498 
19 (health$ policy or health care policy).tw. 46193 
20 exp health planning organisations/ 88280 
21 (health$ planning or health care planning).tw. 8635 
22 exp organizational policy/ 78061 
23 (health$ organi#ation or health care organi#ation).tw. 101395 
24 (health$ system or health care system).mp.  210469 
25 
(resource$ or staff or manpower or financ$ or delivery or governance or 
provid#r).tw. 2031750 
26 facilitator.tw. 13390 
27 accessibility.tw. 74655 
28 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 4632499 
29 14 and 28 564 
30 remove duplicates from 29 422 
31 30 and 2000:2018.(sa_year). 418 
 
This search, re-run for the period June 2017 to Wk 3 August 2018, identified 78 new publications 
 
Web of science search 
((((TOPIC: (cancer) AND TOPIC: (screening)) AND TOPIC: ((colorectal OR breast) OR cervical)) AND 
TOPIC: ((((((((barrier$ OR obstacle$) OR hurdle$) OR challenge$) OR facilitator$) OR health$ service) 
OR health care service) OR health care system) OR health$ system)) AND TOPIC: (systematic reviews 
AND systematic literature reviews)) [115 results – 72 excluding duplicates] 
This search was rerun for the period July 2017 to August 2018 identified X new publications 
Cochrane Search 
Screening AND cancer AND (breast or cervical or colorectal) [52 results – 46 excluding duplicates] 
 
This search was rerun for the period July 2017 to August 2018 identified X new publications 
S1 Table: Search strategy - inclusion criteria  
Category Inclusion Criteria 
Types of study included Systematic reviews (including meta-analysis or narrative synthesis)  
Condition being studied Screening interventions for colorectal, cervical, and breast cancer.  
Participants/population Screening interventions (i.e. targeting people at average risk) in any 
country, region, or locality.  
Intervention/comparator Screening interventions (i.e. targeting people at average risk), with 
and without interventions to increase uptake of screening. 
Primary outcomes Provider-level and system-level barriers and facilitators (e.g. 
contextual factors such as physical resources, human resources, 
intellectual resources, social resources, health system financing, 
governance and delivery).  
Secondary outcomes If available, effects of the barriers and facilitators on the 
effectiveness of the screening interventions  
 
Appendix 2 – Table of included systematic reviews 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Aggarwal, 
A[1] 
2013 US Y Y N Y Y Review current 
evidence on breast 
and cervical cancer 
screening disparities in 
women with mental 
illness. 
Women with 
mental illness 
Breast and cervical 
cancer screening 
Barriers to screening; 
screening utilization; 
factors that encourage 
screening 
Basic science 19 
Albrow, R[2] 2014 UK 
 
N Y N N Y Review interventions 
designed to increase 
cervical screening 
uptake amongst 
women aged 35 years. 
Women aged 35 
years and under 
Interventions 
designed to increase 
cervical screening 
uptake and valid 
comparison group 
Screening uptake in 
women 35 and under 
Comparative 
studies 
4 
Arditi C [3] 2012 UK 
 
Y Y Y N Y Evaluate effects of 
automatic reminders 
delivered on paper to 
healthcare 
professionals on 
processes and 
outcomes of care. 
Qualified 
healthcare 
professionals 
Computer-generated 
reminders delivered 
on paper to 
healthcare 
professionals  
Continuous/ 
dichotomous 
processes/ outcomes of 
care: 
RCTs and non-
RCTs  
32 
Asonganyi, 
E[4] 
2013 US 
 
N Y N Y Y Identify factors 
affecting compliance 
with clinical practice 
guidelines for Pap 
screening among 
healthcare providers in 
Africa. 
Medical 
personnel in 
Africa 
Studies involving 
medical personnel 
practicing in Africa 
Outcome measured any 
factors that affect 
medical personnel from 
using a Pap smear to 
screen for cervical 
cancer 
Observational 
design studies 
(not 
retrospective 
data) 
11 
Azami-
Aghdash, 
S[5] 
2015 IRAN Y N N Y Y Review qualitative 
studies for extracting 
and reporting the 
barriers of screening 
for breast cancer from 
the woman's 
perspective.  
Women eligible 
for screening - 
not further 
specified 
Breast cancer 
screening 
Analysis of barriers 
from women’s 
perspective 
Qualitative 
study 
21 
Azeem, E[6] 2016 SAU N N Y Y  N Compile and analyze 
the various barriers 
towards colorectal 
cancer screening in 
Asia. 
Asian countries Colorectal cancer 
screening 
Barriers preventing 
individuals from 
undergoing colorectal 
cancer screening 
No limitations 23 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Bailey, TM[7] 2005 US Y N N N Y Examine the 
effectiveness of 
educational 
interventions in 
increasing 
mammography 
screening among low-
income women. 
Racial/ethnic 
minority/low 
income women 
Educational, 
community-based 
interventions that 
measured 
mammography 
screening as the 
primary outcome 
Mammography 
screening 
RCTs or 
cohort study 
with control 
24 
Baron, RC[8] 2010 US Y Y Y Y Y Review effectiveness, 
applicability, economic 
efficiency, barriers to 
implementation, and 
other harms or 
benefits of 
interventions designed 
to increase screening 
for breast, cervical, 
and colorectal cancers. 
Service providers Reminder/recall 
interventions to 
increase screening 
for breast, cervical, 
and colorectal 
cancers. These 
interventions involve 
using systems to 
inform healthcare 
providers when 
individual 
clients are due 
(reminder) or 
overdue (recall) for 
specifıc cancer 
screening tests. 
Direction and size of 
effects from provider 
reminder 
interventions to 
increase screening for 
breast, cervical, and 
colorectal cancers 
Comparative 
studies 
(concurrent or 
historic)  
26 
Baron, RC[9] 2008 US Y Y Y Y Y Review effectiveness, 
applicability, economic 
effıciency, barriers to 
implementation, and 
other harms or 
benefıts of provider 
reminder/recall 
interventions to 
increase screening for 
breast, cervical, and 
colorectal cancers. 
Age-eligible 
populations  
Interventions 
designed to increase 
screening for breast, 
cervical, and 
colorectal cancers by 
increasing 
community demand 
for these services - 
Client reminders, 
small media, 
and one-on-one 
education.  
Effectiveness, 
applicability, economic 
efficiency, barriers to 
implementation, and 
other harms or benefits 
  128 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Black, ME 
[10] 
2002 CA N Y N N Y To evaluate and 
summarize evidence of 
the effectiveness of 
interventions 
available to public 
health staff that could 
be used to increase 
cervical cancer 
screening to 
women. 
Women  Interventions 
available to public 
health staff that 
could be used to 
increase cervical 
cancer screening to 
women. The strategy 
could be aimed at 
women or health 
professionals or 
both.  
Effectiveness, 
strategies, increase, 
participation, 
screening, and cervical 
cancer.  Also screening 
knowledge, attitudes or 
behaviours, 
satisfaction, 
and cervical cancer 
incidence/prevalence 
Prospective 
with control 
(one group 
pre/post 
design 
acceptable) 
42 
Bonfill, C[11] 2001, 
2016 
ES Y N N N Y Assess the 
effectiveness of 
different strategies for 
increasing the 
participation rate of 
women invited to 
population-based 
breast cancer 
screening activities or 
mammography 
programs. 
Women invited 
to breast 
screening  
Different strategies 
aimed at improving 
women’s 
participation in 
community 
(population based) 
breast cancer 
screening programs 
and activities. 
Effectiveness of 
different strategies for 
increasing the 
participation rate 
RCTs 16 
Briss, P[12] 2004 US Y Y Y N Y Review of studies of 
informed decision 
making (IDM) 
interventions to 
promote cancer 
screening. 
Developed 
countries 
Met team’s 
definition of the 
intervention.  
Provided information 
on one or more 
outcomes related to the 
analytic framework.  
Primary 
comparative 
study 
11 
Bromley, 
EG[13] 
2015 US N N Y Y N Evaluate barriers to 
colonoscopic 
colorectal cancer 
screening in African 
Americans. 
African 
Americans 45- 75 
years 
Not specified Identified at least one 
patient-, provider-, or 
system-level barrier to 
uptake of screening 
colonoscopy in African 
American 
Not specified 19 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Brouwers, 
MC[14] 
2011 CA Y Y Y Y Y Evaluate interventions 
designed to increase 
the rate of breast, 
cervical, and colorectal 
cancer screening. 
Population 
eligible for 
cancer screening 
- not further 
specified 
Client reminders, 
client incentives, 
mass media, small 
media, group 
education, one on-
one education, 
reduction in 
structural barriers, 
reduction in out-of-
pocket costs, 
provider assessment 
and feedback 
interventions, and 
provider incentives 
Screening rate outcome 
- overall median post-
intervention absolute 
percentage point (PP) 
change in completed 
screening tests. 
RCTs or 
cluster RCTs 
66 
Camilloni, 
L[15] 
2013 IT Y Y Y N Y Systematic review of 
studies assessing the 
efficacy of 
interventions to 
increase participation 
in organised 
population-based 
screening programs. 
Women 50 - 69 
years (breast),  
women 25 - 64 
years (cervical), 
men and women 
50 - 70 years 
(colorectal) 
Interventions, 
strategies, or 
programmes aimed 
at increasing 
participation in 
breast, cervical and 
colorectal cancer 
screenings. Classified 
the interventions 
according to their 
target: individuals, 
communities, health 
operators, or the 
health service 
organization. 
Participation rate Comparative 
studies  
69 
Chorley, 
AJ[16] 
2017 UK N Y N Y N Synthesise the 
qualitative literature 
on women’s 
perceptions and 
experiences of cervical 
screening in the 
context of an 
organised call–recall 
programme. 
Women eligible 
for screening - 
not further 
specified 
Not specified Barriers to cervical 
screening in countries 
that offer a nationally 
organised call–recall 
programme 
Qualitative 
data 
 39 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
de los 
Monteros, 
KE[17] 
2011 US Y Y Y Y N Determine whether 
fatalism predicts 
participation in cancer 
screening after 
accounting for 
structural barriers. 
Latinas Not specified utilization of cancer 
screening services 
Empirical 
studies  
11 
Dinnes, J[18] 2001 UK Y N N  N  Y to compare double 
reading with single 
reading of 
mammograms for 
screening accuracy, 
patient outcomes and 
costs 
Women eligible 
for breast 
screening - not 
further specified 
Mammogram 
reading had to be 
undertaken by two 
people 
Screening accuracy, 
patient outcomes and 
costs. 
RCTs, 
population- 
based cohort 
studies, or 
case-control 
studies  
10 
Donnelly, 
TT[19] 
2015 CA Y N N Y Y Effectiveness of 
interventions in 
increasing breast 
cancer knowledge and 
breast cancer 
screening rates in 
Arabic populations in 
Arabic countries and 
North America. 
Arabic women in 
Arabic region/ 
Western 
multicultural 
society 
Evaluation or 
description of a BCS 
program/educational 
intervention  
Breast cancer 
knowledge and/or 
breast cancer screening 
rates in Arabic women 
Experimental, 
quasi-
experimental, 
or 
longitudinal 
design 
6 
Edwards,  
AGK[20] 
2013 UK Y N Y N Y Assess effects of 
personalised risk 
communication on 
informed decision 
making by individuals 
taking screening tests 
and individual 
components that 
constitute informed 
decisions. 
Individuals 
undergoing 
screening 
procedures - not 
further specified 
Intervention with a 
’personalised risk 
communication 
element’  
Measures of informed 
decisions and also 
cognitive, affective, or 
behavioural outcomes 
addressing the decision 
of whether or not to 
undergo screening 
RCTs 41 
Escoffery, 
C[21] 
2014 US Y Y Y N Y Review the impact of 
special events to 
promote breast, 
cervical or colorectal 
cancer education and 
screening. 
People eligible 
for breast, 
cervical, and/or 
colorectal cancer 
screening in the 
U.S 
Special events to 
promote breast, 
cervical, and/or 
colorectal cancer in 
the U.S. 
Outcomes including 
intentions to get 
screened, scheduled 
appointments, uptake 
of 
clinical exams, and 
participation in cancer 
screening 
Not specified 20 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Everett, 
T[22] 
2011 UK N Y N N Y Assess the 
effectiveness of 
interventions aimed at 
women, to increase 
the uptake, including 
informed uptake, of 
cervical cancer 
screening. 
Women eligible 
for cervical 
cancer screening 
- not further 
specified 
Interventions to 
increase 
uptake/informed 
uptake of cervical 
cancer screening 
(excluding mass 
media/community 
interventions). 
Uptake/informed 
uptake of cervical 
cancer screening 
RCTs and 
cluster RCTs 
38 
Fung-Kee-
Fung, M[23] 
2010  CA N N Y N Y Determine optimal 
colposcopy 
organisation in Ontario 
Canada. 
Organisations, 
practitioners and 
patients relating 
to colposcopy 
services 
Recommendations 
to improve 
colposcopy training, 
qualifications, 
accreditation, 
maintenance of 
competency, 
delivery of 
colposcopy, reducing 
default from 
colposcopy clinics, or 
strategies to 
improve patient 
satisfaction or 
comfort. 
Guidance or outcomes 
relating to improved 
colposcopy training, 
qualifications, 
accreditation, 
maintenance of 
competency, delivery of 
colposcopy, reducing 
default from 
colposcopy clinics, or 
strategies to improve 
patient satisfaction or 
comfort. 
Reports 
including 
guidance 
documents 
16 
Genoff, 
MC[24] 
2016 US Y Y Y N Y Review the literature 
on the impact of 
patient navigators on 
cancer screening for 
limited English 
proficient (LEP) 
patients. 
People eligible 
for breast, 
cervical or 
colorectal cancer 
screening - not 
further specified 
A patient navigator 
intervention to 
provide services 
prior to or during 
cancer screening. A 
comparison of the 
patient navigator 
intervention 
to either a control 
group or another 
intervention. 
Language-specific 
outcomes related to the 
patient 
navigator intervention 
Comparative 
studies 
15 
Glick, SB[25] 2012 US   N Y N N Y Determine which 
interventions improve 
the screening, 
diagnosis or treatment 
of cervical cancer for 
racial and/ or ethnic 
minorities. 
US racial and/or 
ethnic minority 
populations 
At least one 
intervention 
designed to improve 
cervical cancer 
prevention, 
screening, diagnosis 
or treatment 
Health outcomes Original study 31  
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Guessous, 
I[26] 
2010 US N N Y Y Y Identify factors that 
are most consistently 
mentioned as barriers 
or facilitators of 
colorectal cancer  
screening in older 
persons. 
Older persons 
(≥65 years) 
Screening  Barriers to or 
facilitators of CRC 
screening uptake, 
compliance or 
adherence 
Not specified 83 
Hendry, 
M[27] 
2012 UK N Y N Y  N Synthesise evidence of 
women’s information 
needs, views and 
preferences regarding 
HPV testing and 
inform the 
development of 
educational materials. 
Women eligible 
for cervical 
screening - not 
further specified 
HPV testing within 
the UK cervical 
screening 
programme 
Relating to participants’ 
views about HPV testing 
Qualitative or 
quantitative 
studies 
17  
Holden, 
DJ[28] 
2010 US N N Y Y  Y Summarize evidence 
on factors that 
influence colorectal 
cancer screening and 
strategies that 
increase the 
appropriate use and 
quality of screening 
and screening 
discussions. 
People eligible 
for colorectal 
screening - not 
further specified 
Colorectal 
neoplasms, 
colonoscopy, 
sigmoidoscopy  and 
mass screening 
 Screening rates, under 
and over use of 
screening 
Not specified 93 
Honein-
AbouHaidar, 
GN[29] 
2016 CA N N Y Y Y Review and synthesis 
of qualitative studies 
to identify facilitators 
and barriers to 
colorectal cancer 
screening 
participation. 
Adults 50 years 
or over referred 
for colorectal 
screening 
Studies investigating 
perceptions of CRC 
screening as 
well as those 
investigating CRC as 
a disease 
Views and perceptions 
towards colorectal 
cancer screening. 
Perceptions related to 
CRC as a disease, causes 
of CRC, benefits and 
barriers to CRC 
screening, and any 
other contextual factors 
that motivate or 
influence people’s 
decision to 
participate in CRC 
screening 
Primary 
qualitative 
and mixed-
methods 
studies with 
a qualitative 
component 
94 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Hou, SI[30] 2011 KEN Y Y Y N Y Review on cancer 
screening 
interventions among 
Asians. 
Asians 
populations in 
the US and 
overseas 
Interventions to 
increase breast, 
cervical and 
colorectal cancer 
screening  
Improved screening Intervention 
studies 
30  
Hurtado-de-
Mendoza, 
A[31] 
2014 US Y Y N Y y Review on cancer 
behaviors and/or 
interventions in 
African-born 
Immigrants in the US. 
African-born 
immigrant 
participants in 
US 
Cancer screening Screening rates, cancer 
outcomes 
Not specified 
(no case 
studies, 
review etc) 
20 
Javanparast, 
S[32] 
2010 AUST N N Y Y y To review published 
literature on the 
equity of participation 
in colorectal cancer 
screening amongst 
different population 
subgroups, in addition 
to identifying factors 
identified as barriers 
and facilitators to 
equitable screening. 
People eligible 
for colorectal  
screening - not 
further specified 
Included FOBT as at 
least one of the 
screening tests. 
Participation, barriers, 
facilitators 
Qualitative 
and 
quantitative 
studies 
63 
studies 
Jepson, R 
[33] 
2000 UK Y Y Y Y Y  Evaluate the 
determinants of 
screening and 
interventions to 
increase uptake. 
People eligible 
for cancer 
screening - not 
further specified 
Interventions to 
increase 
uptake of screening 
Uptake of screening for 
different diseases and 
factors assoicated 
 
Not specified  65 / 
190 
Jerome-
D'Emilia, 
B[34] 
2015 US Y N N Y y Review the research 
on barriers and 
facilitators to 
mammography in 
Latinas to determine if 
the challenges faced 
by these women are 
unique to this 
population. 
Latinas/Hispanic 
women 40 years 
and older  
Mammography 
screening 
Barriers and facilitators 
to mammography 
utilization 
Quantitative 18 
studies 
Johnson, 
CE[35] 
2008  US N Y N Y Y  Examine sociocultural 
factors influencing 
cervical cancer 
screening among 
immigrant and ethnic 
minorities in the US 
along the health belief 
model. 
Minority and 
immigrant 
populations in 
US 
Cervical cancer 
screening 
Sociocultural factors 
influencing cervical 
cancer screening 
RCTs, 
qualitative, 
surveys, 
secondary 
data analysis 
55 
studies 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Khalid-De 
Bakker, C[36] 
2011  NL N N Y N  Y Review participation 
rate after first-time 
invitation for 
colorectal screening 
with FOBT, 
sigmoidoscopy, 
colonoscopy, and/or 
CT colonography. 
Unselected 
populations  
Invitation for 
screening 
Participation rates  Prospective 
studies 
100  
Khan-Gates, 
JA[37] 
2015 US Y N N N Y Summarize the current 
evidence and gaps in 
the literature on 
geographic access to 
mammography and its 
relationship to breast 
cancer-related 
outcomes. 
Women eligible 
for 
mammography 
in US 
Mammography Geographic accessibility 
and breast cancer-
related outcomes - 
screening and stage at 
diagnosis 
Not specified 21 
Kim, K[38] 2016 US N Y N N Y Critically appraise 
empirical evidence 
investigating pathways 
between health 
literacy (HL) and 
cervical cancer 
screening. 
Women eligible 
for cervical 
cancer screening 
- not further 
specified 
Cervical cancer 
screening 
Measured HL and 
cervical cancer 
screening 
Primary 
studies 
12 
Lee, HY[39] 2010 US Y Y Y Y N Examine the existing 
knowledge regarding 
the barriers to cancer 
screening for Hmong 
Americans. 
Hmong 
Americans 
Not specified Cancer mortality, 
screening, incidence, 
knowledge, or cultural 
beliefs. 
Not specified 26 
Lu, M[40] 2012 CA   Y Y N N Y Update current 
knowledge on the 
effectiveness of 
existing intervention 
strategies to enhance 
breast and cervical 
screening uptake in 
Asian women. 
 Asian women Cancer screening 
interventions 
targeting Asian 
women. 
Effectiveness - self-
reported or recorded 
receipt of 
mammograms or Pap 
smear 
Not specified 37 
Mann, L[41] 2015 US N Y N N Y Explore existing 
interventions to 
increase cervical 
cancer screening 
among US 
Hispanics/Latinas and  
Hispanics/Latinas 
ages 18 years 
and older living 
in the US 
Intervention 
designed to improve 
screening for cervical 
cancer  
Cervical cancer 
screening rates 
Not specified 45 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
identify characteristics 
of effective 
interventions and 
research gaps. 
Masi, CM[42] 2017 US Y N N N Y Identify interventions 
designed to enhance 
breast cancer 
screening, diagnosis, 
and treatment among 
minority women. 
Women eligible 
for breast 
screening - not 
further specified 
Colorectal cancer 
screening - 
intervention that 
was 
health care 
organization-based 
Screening 
mammography rate 
RCTs or 
concurrent 
controlled 
trial 
42 
May, FP[43] 2016 US N N Y Y N Review of the 
literature evaluating 
barriers to 
colonoscopic 
colorectal cancer 
screening in African 
Americans. 
People eligible 
for colorectal 
screening - not 
further specified 
Age appropriate CRC 
screening by 
colonoscopy 
Barriers categorized 
into patient-, provider-, 
and system-related 
factors 
Not specified 19 
McLachlan, 
S[44] 
2009 
- 
used 
2012 
AUST 
 
N N Y Y Y Characterise patients’ 
own experience of 
colonoscopy in the 
screening context. 
People eligible 
for colonoscopy 
screening as a 
primary test or 
follow-up to 
abnormal test 
Colonoscopy Patients’ own 
experience 
of colonoscopy - 
patients’ views, patient-
reported 
barriers 
Original 
studies  - 
questionnaire, 
survey or 
interview 
56 
Morrow, 
JB[45] 
2010 US N N Y N Y  Summarize the current 
literature of 
community-based 
colorectal cancer 
screening randomized 
controlled trials with 
multi-ethnic groups. 
At least two 
racial/ethnic 
groups, with not 
more than 90% 
representation 
from one group 
 all colorectal 
cancer screening test 
interventions 
recommended in the 
2008 ‘‘Joint 
Consensus’’ report 
Screening rates Community- 
based RCTs 
15 
Mullen, 
PD[46] 
2006  US Y Y Y N Y  Interventions to 
promote informed 
decision making for 
cancer screening are 
increasingly common. 
People eligible 
for cancer 
screening - not 
further specified 
Screening decisions 
and decision aids 
Screening (intention) 
and knowledge, IDM 
related constructs 
Interventional 
trials and 
other studies 
36 
Naylor, K[47] 2012 US N  N Y  N Y  Review the literature 
to identify 
interventions that 
improve minority 
≥50 % 
racial/ethnic 
minorities (or 
Study interventions 
were required to 
take place within the 
context of a 
Colorectal cancer 
screening rates 
Experimental 
design 
33 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
health related to 
colorectal cancer care. 
specific sub-
analysis) 
consistent source of 
health care 
(community 
interventions must 
directly integrate a 
system of ongoing 
medical care) 
O’Connor, 
AM[48] 
2009 US 
 
N N Y N Y  Review randomised 
controlled trials 
evaluating the efficacy 
of decision aids for 
people facing difficult 
treatment or screening 
decisions. 
People facing 
difficult 
treatment or 
screening 
decisions 
Interventions 
designed to aid 
patients’ decision 
making compared to 
no intervention, 
usual care, and 
alternatives 
Effectiveness including 
decision attributes and 
decision process  
RCTs 55 
O'Brien, 
M[49] 
2007 CA N Y Y N Y  Review of cancer-
related decision aids. 
Studies of 
patients with 
cancer or at 
increased risk of 
cancer who 
received some 
type of DA were 
included. 
Cancer-related 
Decision Aids about 
screening, 
prevention, and 
treatment  
Effect including 
knowledge, anxiety, 
decisional conflict 
RCTs  34 
Oh KM[50] 2014 US N N Y Y Y  Improving colorectal sc
reening rates in 
Korean Americans 
Korean 
Americans 
CRC screening. Testing, awareness of 
FOBT or sigmoidoscopy 
or colonoscopy 
Not specified 13 
Oh, KM[51] 2017 US Y N N Y  Y Evaluate the full body 
of literature on breast 
cancer screening 
facilitators and 
barriers among Korean 
Americans. 
Korean 
Americans 
Breast cancer 
screening 
Breast examination, 
factors that might 
positively influence 
breast 
cancer screening rates 
Not specified 38 
O'Malley, 
AS[52] 
2003 US   Y Y Y N  Y Examine published 
primary care–based 
cancer control 
interventions that 
included Latinos. 
At least 5% of 
the sample 
Latino 
Any primary care–
based intervention 
Screening utilization. using a 
controlled 
trial, quasi 
experimental, 
or pre–post 
design 
14 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Pannikottu, 
J[53] 
2017 US Y Y Y Y N Review the literature 
for determinants of 
overuse of cancer 
screening for breast 
cancer, cervical cancer, 
and colorectal cancer. 
US population screening for breast 
cancer, cervical 
cancer, and 
colorectal cancer 
Identified determinants 
of cancer screening 
overuse 
Original data 23 
Peterson, 
EB[54] 
2016 US Y Y Y N  Y Analyze studies that 
focused on the role of 
provider-patient 
communication in 
screening behavior for 
cervical, breast, and 
colorectal cancer.  
Primary care 
provider 
Communication was 
face-to-face. 
Screening 
recommendation and 
adherence, cancer 
screening rates 
Peer-
reviewed 
quantitative 
studies 
35 
Plourde, 
N[55] 
2016 CA Y Y N N Y  Identify contextual 
factors at the provider- 
and system-level that 
were associated with 
breast and cervical 
cancer screening 
uptake. 
People eligible 
for breast and 
cervical cancer 
screening - not 
further specified 
breast and 
cervical cancer 
screening 
themes related to 
provider- and 
system-level factors 
associated with 
screening uptake 
Not specified 13 
Powe, 
BD[56] 
2010 US N N Y Y Y  Critically review 
intervention studies 
that aimed to increase 
African-Americans’ 
participation in 
colorectal screening. 
At least 50% of 
sample African-
American, focus 
50 years and 
older 
Intervention to 
increase CRC 
screening 
Barriers to CRC 
screening 
Interventional 
studies 
12 
Pozzi, A[57] 2016 IT Y N N N Y  Synthesize the 
evidence of digital 
breast tomosynthesis 
efficacy. 
Women eligible 
for 
mammography 
Digital breast 
tomosynthesis 
compared with 
conventional 
mammography 
alone. 
recall rates, cancer 
detection rates and/or 
costs  
Interventional 18 
Racey, CS[58] 2011 CA N Y N N Y  Determine to what 
extent providing self-
collected HPV testing 
increases screening 
participation in 
women who are never 
or underscreened for 
cervical cancer. 
Women who did 
not routinely 
participate in 
cervical cancer 
screening 
programs 
 HPV self-testing Cervical cancer 
screening participation. 
Comparative 
interventional 
10 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Riemsma, 
RP[59] 
2002 UK Y N N N  Y Assess the 
effectiveness of 
interventions using a 
stage-based approach 
in bringing about 
positive changes in 
health-related 
behaviour. 
Individuals 
whose behaviour 
could be 
modified, 
primarily in 
order to prevent 
the onset, or 
progression, 
of disease 
Evaluating 
interventions, that 
aimed to influence 
individual health 
behaviour, used 
within a stages-of-
change approach  
Effectiveness in terms 
of outcomes - 
promotion of screening 
mammography 
RCTs 2 
Sabatino, 
SA[60] 
2012 US Y Y Y N Y  Update reviews on the 
effectiveness of 9 of 
the previous 11 
interventions to 
increase screening for 
these cancers. 
Country with a 
high-income 
economy 
Screening use prior 
to intervention 
implementation or a 
concurrent group 
unexposed to the 
intervention 
category of interest 
Provide information on 
at least one cancer 
screening outcome of 
interest 
Primary 
investigation 
of one or 
more 
intervention 
45 
Schoueri-
Mychasiw, 
N[61] 
2013  CA Y N N N Y  Examine whether 
screening 
mammogram 
interventions in 
Canada and other 
countries have 
addressed the needs 
of immigrant and 
minority women. 
Immigrant 
and/or minority 
women in 
Canada or similar 
healthcare (e.g. 
UK/Australia) 
Programs or 
interventions aimed 
at increasing 
mammogram use 
Mammogram 
participation 
Not specified  8 
Schueler, 
KM[62] 
2008 US Y N N Y  N Summarize literature 
related to factors 
associated with receipt 
of mammography. 
Women eligible 
for 
mammography - 
not further 
specified 
Factors affecting 
mammography 
Receipt of 
mammography. 
Not specified 
(excludes 
reviews, 
letters etc) 
195 
Sewitch, 
MJ[63] 
2011 CA N N Y N Y  Review the literature 
on quality that is 
relevant to patients 
who require 
colonoscopy or 
endoscopy services. 
Patients who 
require 
colonoscopy or 
endoscopy 
services. 
regarding aspects of 
colonoscopy and/or 
endoscopy services 
data were collected 
within one year of the 
colonoscopy/endoscopy 
procedure. 
Qualitative 
and 
quantitative 
studies 
8 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Siddiqui, 
MRS[64] 
2011 UK N N Y N  Y Review examining the 
uptake of FOB testing 
after physician 
reminders as part of 
the colorectal cancer 
screening process. 
People eligible 
for colorectal 
cancer screening 
- not further 
specified 
physician reminders 
(Rem) with controls 
(NRem)  
uptake of screening, 
and lack of adherence 
to recommended 
treatment and follow-
up 
Comparative 
studies  
with controls 
5 
Stacey, D[65] 2017 US N Y Y N Y  Assess the effects of 
decision aids in people 
facing treatment or 
screening decisions. 
People facing 
treatment or 
screening 
decisions 
comparing decision 
aids to usual care 
and/or alternative 
interventions 
The primary 
outcomes, based on the 
International Patient 
Decision Aid Standards, 
were: A) decision 
attributes; B) decision 
making process 
attributes. Secondary 
outcomes were 
behavioral, health, and 
health system effects. 
RCTs  105 
Stone, E[66] 2002 US Y Y Y N Y  Assessed the relative 
effectiveness of 
previously studied 
approaches for 
improving adherence 
to adult immunization 
and cancer screening 
guidelines. 
People eligible 
for colon, breast, 
and cervical 
screening  - not 
further specified 
Interventions 
to increase use of  
screening for colon, 
breast, and cervical 
cancer in adults. 
Use of screening for 
colon, breast, and 
cervical 
cancer in adults 
Controlled 
clinical trials 
108 
Taylor, P[67] 2008 UK 
Y 
N N N Y  Review the impact of 
both interventions on 
cancer detection and 
recall rate. 
People eligible 
for breast 
screening  - not 
further specified 
Intervention 
was incorporated 
into routine 
screening work 
Cancer detection and 
recall rate 
Prospective 
and 
retrospective 
studies 
27 
van den 
Biggelaar, 
FJ[68] 
2008 NL Y N N N Y  Review performance 
of radiographers (also 
referring to 
technologists and 
physician assistants) 
compared with 
radiologists in the 
interpretation of 
mammograms. 
Radiographers Mammogram Performance of 
radiographers, 
sensitivity and 
specificity have to be 
reported or calculable 
Not specified 6 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Vedel,  I[69] 2011 CA Y N Y Y Y Determine the barriers 
and facilitators to 
breast and colorectal 
cancer screening of 
older adults, from the 
perspectives of 
patients and primary 
care physicians. 
PCPs or older 
adults  
Breast and colorectal 
cancer screening 
Barriers and facilitators  quantitative 
studies 
published or 
in press 
42 
Viswanathan,  
M[70] 
2009 US   Y Y Y N Y  Review the evidence 
on characteristics of 
community health 
workers and their 
interventions, 
outcomes and 
cost/effectiveness of 
these interventions, 
and characteristics of 
training. 
United States.  CHW interventions 
for improving breast, 
cervical, or 
colorectal cancer 
screening 
Knowledge or health 
care utilization 
outcomes 
Studies 
reporting 
effects 
53 
Wells, KJ[71] 2011, 
2008) 
US Y N N N Y  Synthesize evidence 
from all prospective 
controlled studies on 
effectiveness of 
community health 
worker programs in 
improving screening 
mammography rates. 
Women 40 years 
of age or older 
without a history 
of breast cancer 
CHW intervention 
designed to increase 
screening 
mammography rates 
and evaluated a 
CHW intervention 
outside of a hospital 
setting. 
 Screening 
mammography rates 
RCTs, case-
controlled 
study, or 
quasi-
experimental 
study 
24 
Winawer, 
SJ[72] 
2011  US N N Y N Y  Systematic review of 
colorectal cancer 
screening. 
People eligible 
for colorectal 
screening - not 
further specified 
Colorectal screening Best screening 
approach/options 
Guidelines, 
SRs and 
protocols 
 18 
Wools, A[73] 2016 NL N N Y Y Y Understand the factors 
that are associated 
with colorectal cancer 
screening and follow-
up adherence.  
People eligible 
for colorectal 
screening  - not 
further specified 
Colorectal screening  Factors studied in 
literature were 
identified that are 
associated with CRC 
screening adherence. 
Not specified 77 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of 
Systematic Review 
Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Yabroff, 
KR[74] 
2013,  
2003 
US  N Y N N Y  Review of 
interventions to 
increase Papanicolaou 
smear use. 
People eligible 
for cervical 
screening  - not 
further specified 
Interventions 
classified as targeted 
to patients, 
providers, patients 
and 
providers, or health 
care systems and as 
behavioral, 
cognitive, sociologic, 
or combination  
 Pap smear use Concurrent or 
RCTs 
46 
Yedjou, 
CG[75] 
2017 US  Y N N Y N  Highlight similarities 
and differences in 
breast cancer 
morbidity and 
mortality rates 
primarily among 
African American 
women compared to 
White women in the 
US. 
Primary focus on 
minority health 
 NS Racial/ethnic disparity 
related to breast cancer 
patients 
Not specified  NS 
 
Abstracts in English  
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of Systematic Review Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Bryant-
Lukosius, 
DE[76] 
2015 CA Y Y Y N Y Review which patient populations and 
situations have Advanced Practice Nurse 
roles demonstrated equivalence, 
improved outcomes or reduced harms in 
studies of cancer care.  
People eligible for 
cancer screening - 
not further 
specified 
Evaluated cancer 
services provided by 
amaster's prepared 
clinical nurse 
specialist (CNS) or 
graduate from an 
accredited nurse 
practitioner (NP) 
education program 
Study results - 
efficacy and 
safety 
RCTs or 
comparative 
studies with 
control 
29 
Clarke, 
AR[77] 
2012  US N Y N N Y Characterize interventions with the 
potential to improve the prevention, 
screening, diagnosis, or treatment of 
cervical cancer among racial and ethnic 
minority women. 
US racial/ethnic 
minority 
populations 
At least one 
intervention 
designed to improve 
cervical cancer 
prevention, 
Measured 
medical 
outcomes 
Studies with 
at least one 
intervention  
31 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of Systematic Review Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
screening, diagnosis 
or treatment.  
Deng, 
SX[78] 
2010  CH N N Y Y N Collect and analyze the influencing 
factors of patient compliance with 
colorectal cancer screening in qualitative 
studies to provide a theoretical basis for 
improving compliance. 
People eligible for 
colorectal 
screening - not 
further specified 
Not specified Patient 
compliance 
Qualitative 
studies 
15 
Dreier, 
M[79] 
2012 DE Y Y N Y Y Investigate women’s knowledge of, 
attitudes to and participation in 
screening measures and determinants of 
eligible women living in Germany. 
Women eligible 
for breast and 
cervical screening 
- not further 
specified 
Mammography and 
cervical cancer 
screening 
Women’s 
knowledge of, 
attitudes to and 
participation in 
these screening 
measures  
Not specified 12 
Ekwueme, 
DU[80] 
2009 US Y N N N Y Assemble a knowledge base of studies in 
low/middle income countries on breast 
cancer prevention, early detection, 
treatment, and palliative care that 
address issues of equity, access, and 
costs. 
Low and middle 
income countries 
Breast cancer 
prevention, early 
detection, 
treatment, and 
palliative care that 
address issues of 
equity, access, and 
costs 
Breast cancer 
prevention, 
early 
detection, 
treatment, and 
palliative care 
that address 
issues of equity, 
access, and 
costs 
Not specified 516 
Geng, 
ZZ[81] 
2013  US N N Y N Y Review of studies that tested 
interventions for increasing screening 
among the underserved. 
Underserved 
populations  
Inreach and outreach 
interventions for 
increasing screening 
among underserved 
populations 
Screening 
participation. 
RCTs 42 
Gibbons, 
MC[82] 
2007 US  Y Y N N Y Examination of randomized controlled 
trial evidence regarding the usefulness of 
community health workers (CHWs) in the 
U.S. health care system.  
People eligible for 
screening - not 
further specified 
CWT intervention CHW efficacy RCTs  12 
Giorgi 
Rossi, 
P[83] 
2013 IT N Y N N y Review the effect self-sampling on 
screening participation.  
Underscreened or 
non-responder 
25-64 year old 
women 
Mailing self-sampling 
device, standard or 
enhanced recall for 
Pap-test at clinic  
Screening 
participation 
RCTs 9 
1st Author Year Country  
1st 
Author 
Br Ce Co Barrier  Facilitator Objective of Systematic Review Population Intervention/ 
Comparison 
Outcome Study types No. 
studies  
Giorgi 
Rossi, 
P[84] 
2012 IT Y Y Y N Y Synthesize scientific evidence about 
methods to increase cervical, breast and 
colorectal cancer screening participation. 
Individual, 
community, test 
simplification, 
health operators, 
health service 
organization. 
Methods to increase 
cervical, breast and 
colorectal cancer 
screening 
participation. 
Increasing 
participation 
Experimental 
and 
observational 
studies 
238 
Keihanian, 
T[85] 
2015 US N N Y Y N Identify the potential barriers to 
colorectal cancer screening among 
minorities in the US, focusing on 
Hispanic and African-American 
population.  
Ethnic minorities 
and underserved 
population in the 
United States 
Organised screening 
programmes, based 
on invitation letter or 
on GP involvement 
Effectiveness in 
increasing 
participation 
compared to 
spontaneous 
screening 
Not specified  16 
Kien, C[86] 2015 AU Y N Y N Y  Assess whether task shifting  from 
physicians to other medical staff is 
appropriate for screening and whether it 
compromises patients' health outcomes 
and experiences. 
People eligible for 
screening  - not 
further specified 
Colon cancer 
screening, 
mammography, 
genetic risk 
counselling 
Patients’ health 
outcomes and 
experiences. 
Not specified 5 
Kizior, 
AM[87] 
2014  POL N Y N N Y Review the literature on perceived 
individual barriers and benefits 
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clinical screening of at-risk relatives for familial 
adenomatous polyposis. 
No reporting of barriers to screening or interventions to 
improve  
Christy S.M.[56] 
 
 
Shared decision-making about colorectal cancer 
screening: A conceptual framework to guide research. Non-systematic reviews 
Consedine N.S.[57] 
 
 
Fear, anxiety, worry, and breast cancer screening 
behavior: A critical review. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Cooper K.[58] 
 
 
 
 
Chemoprevention of colorectal cancer: Systematic review 
and economic evaluation. Not screening programme related 
Corkum M.[59] 
 
 
Screening for new primary cancers in cancer survivors 
compared to non-cancer controls: A systematic review 
and meta-analysis. 
No reporting of barriers to screening or interventions to 
improve  
Corrarino J.E.[60] Health Literacy and Women's Health: Challenges and Opportunities. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Curran J.[61] 
How effective is mammography in detecting breast 
cancer recurrence in women after Breast Conservation 
Therapy (BCT) - A systematic literature review. 
Cancer treatment and care 
D'Andrea E.[62] 
 
 
Which BRCA genetic testing programs are ready for 
implementation in health care? A systematic review of 
economic evaluations. 
Targeted screening (at risk) or diagnostics (symptoms)  
Das V.[63] 
 
 
Predictive and prognostic biomarkers in colorectal 
cancer: A systematic review of recent advances and 
challenges. 
Targeted screening (at risk) or diagnostics (symptoms)  
De Morgan S.[64] Communicating prognosis and treatment of DCIS: Challenges arising from a diagnosis of uncertainty. Screening for other cancers/diseases 
DeBarros M.[65] 
 
 
Colorectal cancer screening in an equal access healthcare 
system. Non-systematic reviews 
DeFrank J.T.[66] 
 
 
 
The Psychological Harms of Screening: the Evidence We 
Have Versus the Evidence We Need. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Demment M.M.[67] 
 
 
Developing the evidence base to inform best practice: A 
scoping study of breast and cervical cancer reviews in 
low- and middle-income countries. 
Cancer treatment and care 
Denny L.[68] 
 The prevention of cervical cancer in developing countries. Non-systematic reviews 
DeWalt D.A.[69] 
 
 
Literacy and health outcomes: A systematic review of the 
literature. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Dhana A.[70] 
 
 
Systematic review of facility-based sexual and 
reproductive health services for female sex workers in 
Africa. 
Targeted screening (at risk) or diagnostics (symptoms)  
Dhana A[70] DUPLICATE 
 
 
Systematic review of facility-based sexual and 
reproductive health services for female sex workers in 
Africa. [Review] 
Targeted screening (at risk) or diagnostics (symptoms)  
Dhanji Z.[71] 
 
 
Cervical screening reminder calls pilot: Utilizing EMRs to 
improve cancer screening. 
Other study types (controlled trials, observational 
studies) 
Dieng M[72] 
Improving cancer risk understanding: A systematic review 
of  educational interventions for people with, or at high 
risk of, cancer 
Targeted screening (at risk) or diagnostics (symptoms) 
Dietz J.R.[73] 
 
 
Breast Cancer Management Updates: Young and Older, 
Pregnant, or Male. Not screening programme related 
Dillner J.[74] Primary human papillomavirus testing in organized cervical screening. 
No reporting of barriers to screening or interventions to 
improve  
Dinnes J.[75] 
 
. 
 
 
Effectiveness and cost-effectiveness of double reading of 
mammograms in breast cancer screening: Findings of a 
systematic review. 
No reporting of barriers to screening or interventions to 
improve  
Domgue J.B.F.[76] 
 
 
Alternative methods for primary cervical cancer screening 
in sub-Saharan Africa: A systematic review and meta-
analysis of accuracy of VIA, VILI and HPV testing. 
No reporting of barriers to screening or interventions to 
improve  
Ekwunife O.I.[77] 
 
 
Challenges in Cost-Effectiveness Analysis Modelling of 
HPV Vaccines in Low- and Middle-Income Countries: A 
Systematic Review and Practice Recommendations. 
No reporting of barriers to screening or interventions to 
improve  
Eleje G.U.[78] 
 
Palliative interventions for controlling vaginal bleeding in 
advanced cervical cancer. Cancer treatment and care 
Elit L.[79] 
 
 
 
Cervical Cancer Prevention in Low-Resource Settings. No reporting of barriers to screening or interventions to improve  
Ellis P[80] 
 
 
A systematic review of studies evaluating diffusion and 
dissemination of selected cancer control interventions. 
[Review] [100 refs] 
No reporting of barriers to screening or interventions to 
improve 
Emery J.D.[81] 
 
The challenges of early diagnosis of cancer in general 
practice. No abstract in a European Union language 
Endzelins E.[82] 
 
 
Diagnostic, prognostic and predictive value of cell-free 
miRNAs in prostate cancer: A systematic review. Screening for other cancers/diseases 
Escoffery C.[83] 
 
 
A grey literature review of special events for promoting 
cancer screenings. Non-systematic reviews 
Escoffery C[83] 
DUPLICATE 
A grey literature review of special events for promoting 
cancer screenings. Non-systematic reviews 
Ewald N.[84] 
 
 
Pyruvate kinase M2 (tumor M2-PK) as a screening tool for 
colorectal cancer (CRC) - A review. [German] Targeted screening (at risk) or diagnostics (symptoms)  
Ezendam N.[85] 
 
 
Health literacy in cancer patients: State of the art and 
future directions. Cancer treatment and care 
Fahrbach K.[86] 
 
 
A comparison of the accuracy of two minimally invasive 
breast biopsy methods: A systematic literature review 
and meta-analysis. 
Targeted screening (at risk) or diagnostics (symptoms)  
Falk D.[87] A systematic review of breast and cervical cancer prevention interventions for latinas. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Farshid G.[88] 
 
 
Mucocele-like lesions of the breast: A benign cause for 
indeterminate or suspicious mammographic 
microcalcifications. 
Not screening programme related 
Fernandes R.[89] 
 
 
Optimal primary febrile neutropenia prophylaxis for 
patients receiving docetaxel-cyclophosphamide 
chemotherapy for breast cancer: a systematic review. 
Not screening programme related 
Fesenfeld M.[90] 
 
 
Cost-effectiveness of human papillomavirus vaccination 
in low and middle income countries: A systematic review. 
No reporting of barriers to screening or interventions to 
improve  
Finocchario-Kessler S.[91] 
 
Cervical cancer prevention and treatment research in 
Africa: A systematic review from a public health 
perspective. 
No reporting of barriers to screening or interventions to 
improve  
Flanagan S.M.[92] 
 
 
Adverse outcomes after colposcopy. Not screening programme related 
Fleeman N.[93] 
 
 
 
 
The clinical effectiveness and costeffectiveness of 
genotyping for CYP2D6 for the management of women 
with breast cancer treated with tamoxifen: A systematic 
review. 
Cancer treatment and care 
Forbat L.[94] 
 
Family history of breast cancer: Clinical implications for 
relational health promotion derived from a systematic 
review. 
Targeted screening (at risk) or diagnostics (symptoms)  
Forhan S.E.[95] 
 
 
A systematic review of the effects of visual inspection 
with acetic acid, cryotherapy, and loop electrosurgical 
excision procedures for cervical dysplasia in HIV-infected 
women in low- and middle-income countries. 
Not screening programme related 
Foster C.[96] 
 
 
Web-based decision aids to support young women with 
breast cancer. Cancer treatment and care 
Frederiksen M.E.[97] 
 
 
What women want. Women's preferences for the 
management of low-grade abnormal cervical screening 
tests: A systematic review. 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Freeberg J.A.[98] 
 
 
The clinical effectiveness of fluorescence and reflectance 
spectroscopy for the in vivo diagnosis of cervical 
neoplasia: An analysis by phase of trial design. 
Not screening programme related 
Frego M.[99] 
 
 
Dysplasia in ulcerative colitis: Still a challenge. Screening for other cancers/diseases 
Fu, Mei R[100] 
 
 
Psychosocial impact of lymphedema: A systematic review 
of literature from 2004 to 2011. [References]. Screening for other cancers/diseases 
Gadducci A.[101] 
 
Smoking habit, immune suppression, oral contraceptive 
use, and hormone replacement therapy use and cervical 
carcinogenesis: A review of the literature. 
Not screening programme related 
Gajjar K.[102] 
 
 
Pain relief for women with cervical intraepithelial 
neoplasia undergoing colposcopy treatment. 
No reporting of barriers to screening or interventions to 
improve  
Garbee D.[103] 
 
 
The impact of side effects on adherence and persistence 
with oral anti-cancer agents in women diagnosed with 
early stage breast cancer: A systematic review of 
quantitative evidence protocol. 
Not screening programme related 
Garrett M.M.[104] 
 
 
Strategies to improve colorectal cancer screening rates. Non-systematic reviews 
Gaskie S.[105] 
 
 
Are breast self-exams or clinical exams effective for 
screening breast cancer?. 
No reporting of barriers to screening or interventions to 
improve  
Gatsonis C.[106] 
 
 
Meta-analysis of diagnostic and screening test accuracy 
evaluations: Methodologic primer. 
No reporting of barriers to screening or interventions to 
improve  
Gelband H.[107] 
 
 
 
Costs, affordability, and feasibility of an essential package 
of cancer control interventions in low-income and 
middle-income countries: Key messages from Disease 
Control Priorities, 3rd edition. 
No reporting of barriers to screening or interventions to 
improve  
Gierisch JM[108] Prioritization of research addressing management strategies for ductal carcinoma in situ. 
No reporting of barriers to screening or interventions to 
improve 
Gimeno Garcia A.Z.[109] 
 
 
Public awareness of colorectal cancer screening: 
Knowledge, attitudes, and interventions for increasing 
screening uptake. 
Non-systematic reviews 
Goddard K.A.B.[110] 
 
 
 
Building the evidence base for decision making in cancer 
genomic medicine using comparative effectiveness 
research. 
Targeted screening (at risk) or diagnostics (symptoms)  
Goldsmith MR[111] 
 
 
Synthesising quantitative and qualitative research in 
evidence-based patient information. 
No reporting of barriers to screening or interventions to 
improve  
Gudgeon J.M.[112] 
 
 
Lynch syndrome screening implementation: Business 
analysis by a healthcare system. Screening for other cancers/diseases 
Gutierrez L.Q.[113] 
 
 
Review of an economic analysis of the emerging 
technologies in oncology. [Spanish] 
No reporting of barriers to screening or interventions to 
improve  
Habbema J.D.F.[114] 
 Models in the development of clinical practice guidelines. 
Hackney L.[115] 
Review of the evidence on the use of arbitration or 
consensus within breast screening: A systematic scoping 
review. 
No reporting of barriers to screening or interventions to 
improve 
Hakonsen S.J.[116] 
 
 
Diagnostic accuracy of a validated screening tool for 
monitoring nutritional status in patients with colorectal 
cancer: A systematic review protocol. 
Cancer treatment and care 
Hakonsen S.J.[117] 
 
 
Diagnostic test accuracy of nutritional tools used to 
identify undernutrition in patients with colorectal cancer: 
A systematic review. 
No reporting of barriers to screening or interventions to 
improve  
Hamilton J.G.[118] 
 
Primary care providers' cancer genetic testing-related 
knowledge, attitudes, and communication behaviors: A 
systematic review and research agenda. 
Targeted screening (at risk) or diagnostics (symptoms)  
Hammond W.A.[119] 
 Pharmacologic resistance in colorectal cancer: A review. Not screening programme related 
Harris R.[120] 
 
 
Reconsidering the criteria for evaluating proposed 
screening programs: Reflections from 4 current and 
former members of the U.S. preventive services task 
force. 
No reporting of barriers to screening or interventions to 
improve  
Haugsdal M.L.[121] 
 
 
HPV and Cervical Dysplasia in Adolescents: A Progressive 
March Toward Prevention. Not screening programme related 
Havlicek A.J. 
 [122] 
 
The community pharmacist's role in cancer screening and 
prevention. Non-systematic reviews 
Hay J.L.[123] 
 
 
Does worry about breast cancer predict screening 
behaviors? A meta-analysis of the prospective evidence. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Heitman S.J.[124] 
 
 
Colorectal cancer screening for average-risk north 
americans: An economic evaluation. 
No reporting of barriers to screening or interventions to 
improve  
Heitman SJ[125] 
 
 
Colorectal cancer screening for average-risk North 
Americans: an economic evaluation.[Erratum appears in 
PLoS Med. 2012 Nov;9(11). doi: 
No reporting of barriers to screening or interventions to 
improve  
10.1371/annotation/0fd49c83-2c6d-42b5-a8c1-
45a0aaedaa77] 
Hendry M.[126] 
 
 
"HPV? Never heard of it!": A systematic review of girls' 
and parents' information needs, views and preferences 
about human papillomavirus vaccination. 
Not screening programme related 
Heresbach D.[127] 
 
 
CT colonoscopy in 2007: The next standard for colorectal 
cancer screening in average-risk subjects?. No abstract in a European Union language 
Herrmann A.[128] 
 
 
Examining where research efforts on cancer-related 
decision aids have been made. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Hewitson P.[129] 
 
 
Screening for colorectal cancer using the faecal occult 
blood test, Hemoccult. 
No reporting of barriers to screening or interventions to 
improve  
Hewitson P[129] 
DUPLICATE 
 
 
Screening for colorectal cancer using the faecal occult 
blood test, Hemoccult. [Review] [46 refs][Update of 
Cochrane Database Syst Rev. 2000;(2):CD001216; PMID: 
10796760] 
No reporting of barriers to screening or interventions to 
improve  
Hirschhorn L.R.[130] 
 
Cancer and the 'other' noncommunicable chronic 
diseases in older people living with HIV/AIDS in resource-
limited settings: A challenge to success. 
Targeted screening (at risk) or diagnostics (symptoms)  
Husereau D.[131] 
 
 
Health Technology Assessment: A Review of International 
Activity and Examples of Approaches With Computed 
Tomographic Colonography. 
No reporting of barriers to screening or interventions to 
improve  
Hwang E.S.[132] 
 
 
Patterns of breast magnetic resonance imaging use an 
opportunity for data-driven resource allocation. Not screening programme related 
Idy S.R.[133] Information needs and patient satisfaction among colorectal cancer patients. Cancer treatment and care 
Ilbawi A.M.[134] 
 
 
Global Cancer Consortiums: Moving from Consensus to 
Practice. 
No reporting of barriers to screening or interventions to 
improve  
Ilic D[135] 
 
 
Screening for prostate cancer. [Review][Update of 
Cochrane Database Syst Rev. 2006;(3):CD004720; PMID: 
16856057] 
Screening for other cancers/diseases 
Jacob I.[136] 
 
 
Evalua ting the economic impact of technological 
advances in diagnostics: The case of high throughput 
sequencing for hereditary breast cancer. 
Targeted screening (at risk) or diagnostics (symptoms)  
Janssens J.F.[137] Faecal occult blood test as a screening test for colorectal cancer. Non-systematic reviews 
Jatoi I.[138] 
 
 
Cancer screening. Non-systematic reviews 
Jensen A.E.[139] 
 
 
Panel management in primary care: A systematic review. No reporting of barriers to screening or interventions to improve  
Jentschke M.[140] 
Systematic comparison of different meta-analyses, 
systematic reviews and HTA reports on cervical cancer 
screening based on cytology or HPV test. 
No reporting of barriers to screening or interventions to 
improve  
Jentschke M.[141]  
 
 
Systematic comparison of different meta-analyses, 
systematic reviews and HTA reports on cervical cancer 
screening based on cytology or HPV test. [German] 
No reporting of barriers to screening or interventions to 
improve  
Jeong K.E.[142] 
 
 
Review of economic evidence in the prevention and early 
detection of colorectal cancer. 
No reporting of barriers to screening or interventions to 
improve  
Jones C.E.L.[143] 
 
 
A systematic review of barriers to early presentation and 
diagnosis with breast cancer among black women. Targeted screening (at risk) or diagnostics (symptoms)  
Jones CE[143] 
 
 
A systematic review of barriers to early presentation and 
diagnosis with breast cancer among black women. 
[Review] 
Not screening programme related 
Jones S.C.[144]  
 
 
Womens awareness of cancer symptoms: A review of the 
literature. Targeted screening (at risk) or diagnostics (symptoms)  
Jorgensen K.J.[145] 
 
Mammography screening. Benefits, harms, and informed 
choice. 
No reporting of barriers to screening or interventions to 
improve  
Juhl Jorgensen K.[146] 
 Mammography screening. 
No reporting of barriers to screening or interventions to 
improve  
Karnon J.[147] 
 
Liquid-based cytology in cervical screening: An updated 
rapid and systematic review and economic analysis. 
No reporting of barriers to screening or interventions to 
improve  
Karnon J[147] DUPLICATE 
 
 
Liquid-based cytology in cervical screening: an updated 
rapid and systematic review and economic analysis. 
[Review] [119 refs] 
No reporting of barriers to screening or interventions to 
improve  
Kearney A.J.[148] Viewpoint: It is time to reconsider policy for population-based mammography screening. Non-systematic reviews 
Khan N.F.[149] 
 
Long-term survivors of adult cancers and uptake of 
primary health services: A systematic review. Cancer treatment and care 
Khodakarami n. [150] The new guideline for cervical cancer screening in low risk Iranian women. [Persian] 
Kiechle E.S.[151] 
 
 
Different Measures, Different Outcomes? A Systematic 
Review of Performance-Based versus Self-Reported 
Measures of Health Literacy and Numeracy. 
Screening for other cancers/diseases 
Kizior A.[152] 
 
 
Barriers to participation in breast and cervical cancer 
screening (analysis of international research). Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Kolahdooz F[153] 
 
Knowledge, attitudes, and behaviours towards cancer 
screening in indigenous populations: a systematic review. 
[Review] 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Konrad G.[154] Dietary interventions for fecal occult blood test screening: Systematic review of the literature. 
No reporting of barriers to screening or interventions to 
improve  
Kramer B.S.[155] 
 
 
Use of 5alpha-Reductase Inhibitors for Prostate Cancer 
Chemoprevention: American Society of Clinical Screening for other cancers/diseases 
 
 
Oncology/American Urological Association 2008 Clinical 
Practice Guideline. 
Kramer B.S.[156] 
 
 
Getting it right: Being smarter about clinical trials - A 
major NIH meeting led to recommendations for 
conducting better clinical trials. 
Not screening programme related 
Kremers HM[157] 
 
 
Preventive medical services among patients with 
rheumatoid arthritis. Screening for other cancers/diseases 
Kyrgiou M.[158] 
 
 
 
Management of minor cervical cytological abnormalities: 
A systematic review and a meta-analysis of the literature. 
No reporting of barriers to screening or interventions to 
improve  
Kyrgiou M.[159] 
 
 
Obstetric outcomes after conservative treatment for 
intraepithelial or early invasive cervical lesions: 
Systematic review and meta-analysis. 
Cancer treatment and care 
Labianca R.[160] 
 
 
Challenges in the treatment of gastrointestinal tumours. Screening for other cancers/diseases 
Lam K.[161] 
 
 
DNA methylation based biomarkers in colorectal cancer: 
A systematic review. Cancer treatment and care 
Lamb G.C.[162] 
 Does public reporting impact quality of care inwisconsin?. 
No reporting of barriers to screening or interventions to 
improve  
Lange M.[163] 
 
 
Cognitive dysfunctions in elderly cancer patients: A new 
challenge for oncologists. Not screening programme related 
Lansdorp-Vogelaar I.[164] 
 
 
Cost-effectiveness of colorectal cancer screening. No reporting of barriers to screening or interventions to improve  
Launois R.[165] 
Systematic review and bivariate/HSROC meta-analysis of 
immunochemical and guaiac fecal occult blood tests for 
colorectal cancer screening 
No reporting of barriers to screening or interventions to 
improve 
Lawal O.[166] 
 
 
Mammography screening in Nigeria - A critical 
comparison to other countries. Non-systematic reviews 
Le M.T.[167] 
 
 
Is the false-positive rate inmammography in North 
America too high?. Non-systematic reviews 
Lee S.J.[168] 
 
 
Antenatal breast examination for promoting 
breastfeeding. Not screening programme related 
Leung D.Y.P.[169] 
 
 
Contributing factors to colorectal cancer screening 
among Chinese people: A review of quantitative studies. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Lewis C.L.[170] Colorectal cancer: screening. No reporting of barriers to screening or interventions to improve  
Lewis CL[170] DUPLICATE Colorectal cancer: screening. [Review] No reporting of barriers to screening or interventions to improve  
Lieberman D.[171] 
 
 
 
 
Standardized colonoscopy reporting and data system: 
report of the Quality Assurance Task Group of the 
National Colorectal Cancer Roundtable. 
No reporting of barriers to screening or interventions to 
improve  
Lin Q.[172] 
 
 
The role of pharmaceutical care in the oncology 
department. Cancer treatment and care 
Lockwood S.[173] 
 
 
Cost-effectiveness of serum CA125 compared to 
transvaginal ultrasound as a screening test for ovarian 
cancer: A systematic review protocol. 
No reporting of barriers to screening or interventions to 
improve  
Lowery J.T.[174] 
 
 
 
Understanding the contribution of family history to 
colorectal cancer risk and its clinical implications: A state-
of-the-science review. 
Targeted screening (at risk) or diagnostics (symptoms)  
Lusardi M.M.[175] 
 
Using walking speed in clinical practice: Interpreting age-, 
gender-, and function-specific norms. Not screening programme related 
Lyman G.H.[176] 
 
 
The challenge of systematic reviews of diagnostic and 
staging studies in cancer. 
No reporting of barriers to screening or interventions to 
improve  
Maciosek M.V.[177] 
 
 
Priorities Among Effective Clinical Preventive Services. 
Results of a Systematic Review and Analysis. 
No reporting of barriers to screening or interventions to 
improve  
Mai V.[178] 
 
 
Ontario Cervical Cancer Screening Clinical Practice 
Guidelines. 
No reporting of barriers to screening or interventions to 
improve  
Malila N.[179] 
 
 
European guidelines for quality assurance in colorectal 
cancer screening and diagnosis. First Edition 
Organisation. 
No reporting of barriers to screening or interventions to 
improve  
Manca D.P.[180] 
 Closing arguments - Yes. No abstract in a European Union language 
Mandelblatt J.[181] 
 
 
The cost-effectiveness of screening mammography 
beyond age 65 years: a systematic review for the U.S. 
Preventive Services Task Force. 
No reporting of barriers to screening or interventions to 
improve  
Mansfield C.[182] Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990-2013. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Marks D[183] 
 
 
Screening for hypercholesterolaemia versus case finding 
for familial hypercholesterolaemia: a systematic review 
and cost-effectiveness analysis. [Review] [134 refs] 
Screening for other cancers/diseases 
McCombie A.[184] 
 
 
Computerised Cognitive Behavioural Therapy for 
Psychological Distress in Patients with Physical Illnesses: 
A Systematic Review. 
Not screening programme related 
McLachlan SA[185] 
 
 
Patients' experiences and reported barriers to 
colonoscopy in the screening context--a systematic 
review of the literature. [Review] 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
McLachlin CM[186] 
 
 
Ontario cervical cancer screening clinical practice 
guidelines. [Review] [45 refs] 
No reporting of barriers to screening or interventions to 
improve  
Melnikow, Joy[187] 
 
 
Counterpoint: Randomized trials provide the strongest 
evidence for clinical guidelines: The US Preventive 
Services Task Force and prostate cancer screening. 
[References]. 
Screening for other cancers/diseases 
Meyerson B.E.[188] 
 
Increasing efforts to reduce cervical cancer through state-
level comprehensive cancer control planning. 
 
Non-systematic reviews 
Mezei A.K.[189] 
 
 
Cost-effectiveness of cervical cancer screening methods 
in low- and middle-income countries: A systematic 
review. 
No reporting of barriers to screening or interventions to 
improve  
Mills E.D.[190] A review of sexual health care access and outcomes among women who have sex with women. Not screening programme related 
Molina Y.[191] 
 
 
Breast cancer interventions serving US-based Latinas: 
Current approaches and directions. Non-systematic reviews 
Montella M.[192] 
 
 
Determinant factors for diagnostic delay in operable 
breast cancer patients. 
Other study types (controlled trials, observational 
studies) 
Moore S.P.[193] 
 
 
Cancer incidence in indigenous people in Australia, New 
Zealand, Canada, and the USA: A comparative 
population-based study. 
Not screening programme related 
Mori R.[194] Human papillomavirus vaccines: Global versus Japanese situations. Not screening programme related 
Mork M.[195] 
 
 
Lynch Syndrome: A Primer for Urologists and Panel 
Recommendations. Screening for other cancers/diseases 
Morton R.[196] 
 
 
Economic analysis of the breast cancer screening 
program used by the UK NHS: Should the program be 
maintained?. 
Other study types (controlled trials, observational 
studies) 
Murphy J.[197] 
 
 
HPV Testing in Primary Cervical Screening: A Systematic 
Review and Meta-Analysis. 
No reporting of barriers to screening or interventions to 
improve  
Murphy J.[198] 
 
 
Cervical Screening: A Guideline for Clinical Practice in 
Ontario. 
No reporting of barriers to screening or interventions to 
improve  
Murphy J.[199] 
 
 
The organization of colposcopy services in Ontario: 
Recommended framework. 
No reporting of barriers to screening or interventions to 
improve  
Muszbek N.[200] 
 
 
Economic evaluation of population-based mass screening 
for the early detection of cancer: a systematic review. 
[Hungarian] 
No reporting of barriers to screening or interventions to 
improve  
Nahvijou A.[201] 
 
 
 
 
A systematic review of economic aspects of cervical 
cancer screening strategies worldwide: discrepancy 
between economic analysis and policymaking. 
No reporting of barriers to screening or interventions to 
improve  
Newall A.T.[202] 
 
 
Cost-effectiveness analyses of human papillomavirus 
vaccination. 
No reporting of barriers to screening or interventions to 
improve  
Nicholson F.B.[203] 
 
 
 
 
Review article: Population screening for colorectal 
cancer. Non-systematic reviews 
Norredam M.[204] 
 
 
Migrants' utilization of somatic healthcare services in 
Europe--a systematic review. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Okabayashi K.[205] Body mass index category as a risk factor for colorectal adenomas: A systematic review and meta-analysis. Not screening programme related 
Oosterhoff M.[206] A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers. Not screening programme related 
Padgett L.[207] The American cancer society survivorship guidelines: From systematic review to dissemination tools. 
No reporting of barriers to screening or interventions to 
improve  
Papagrigoriadis S.[208] 
 
Follow-up of patients with colorectal cancer: The 
evidence is in favour but we are still in need of a 
protocol. 
Cancer treatment and care 
Patchell S.[209] 
 
 
Is bioimpedance spectroscopy the most effective way of 
screening for lymphedema following breast cancer? a 
systematic review. 
Cancer treatment and care 
Patel H.[210] 
 
 
Knowledge of human papillomavirus and the human 
papillomavirus vaccine in European adolescents: A 
systematic review. 
Not screening programme related 
Payne S.[211] 
Not an equal opportunity disease - a sex and gender-
based review of colorectal cancer in men and women: 
Part I. 
No reporting of barriers to screening or interventions to 
improve 
Pearce A.[212] 
 
Are the true impacts of adverse events considered in 
economic models of antineoplastic drugs? a systematic 
review. 
Cancer treatment and care 
Perlman S.[213] 
 
 
Knowledge and awareness of HPV vaccine and 
acceptability to vaccinate in sub-Saharan Africa: A 
systematic review. 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Petelin L.[214] 
 
 
A systematic review of comparative effectiveness models 
and economic evaluations for cancer risk management 
strategies in brca1/2 mutation carriers. 
Not screening programme related 
Phillips K.A.[215] 
 
 
A review of studies examining stated preferences for 
cancer screening. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Pignone M.[216] 
 
 
Challenges in systematic reviews of economic analyses. No reporting of barriers to screening or interventions to improve  
Pignone M.[217]  
 
 
Cost-effectiveness analyses of colorectal cancer 
screening: A systematic review for the U.S. Preventive 
Services Task Force. 
No reporting of barriers to screening or interventions to 
improve 
Pignone M.P.[218] 
 
Costs and cost-effectiveness of full implementation of a 
biennial faecal occult blood test screening program for 
bowel cancer in Australia. 
No reporting of barriers to screening or interventions to 
improve  
 
 
Pinzon Florez C.E.[219] 
 
 
Cost-effectiveness of screening and early detection 
strategies for colorectal cancer in Colombia. 
No reporting of barriers to screening or interventions to 
improve  
Porte F.[220] 
 
CT colonography for surveillance of patients with 
colorectal cancer: Systematic review and meta-analysis of 
diagnostic efficacy. 
Other study types (controlled trials, observational 
studies) 
Porzsolt, Franz [Ed][221] 
 
 
Optimizing health: Improving the value of healthcare 
delivery. Not screening programme related 
Pothiwala P.[222] 
 
 
Ethnic variation in risk for osteoporosis among women: A 
review of biological and behavioral factors. Screening for other cancers/diseases 
Praditsitthikorn N.[223] 
 
. 
Economic evaluation of policy options for prevention and 
control of cervical cancer in Thailand. 
No reporting of barriers to screening or interventions to 
improve  
Prince A.E.R.[224] 
 
Is there evidence that we should screen the general 
population for lynch syndrome with genetic testing? A 
systematic review. 
Screening for other cancers/diseases 
Pron G.[225] 
Prostate-specific antigen (Psa)-based population 
screening for prostate cancer: An evidence-based 
analysis. 
Screening for other cancers/diseases 
Pron G[225] DUPLICATE 
Prostate-Specific Antigen (PSA)-Based Population 
Screening for Prostate Cancer: An Evidence-Based 
Analysis. [Review] 
Screening for other cancers/diseases 
Pruitt S.L.[226] 
 
 
Association of area socioeconomic status and breast, 
cervical, and colorectal cancer screening: A systematic 
review. 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Pruitt, Sandi L[227] The association of area socioeconomic status and cancer screening: A systematic review and multilevel study. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Qasim A.[228] 
 
 
Primary prevention of colorectal cancer: Are we closer to 
reality?. Non-systematic reviews 
Qureshi Z.[229] 
 
 
Battling fear: A potential key to improving colorectal 
cancer screening. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Raichand S.[230] 
Conclusions in systematic reviews of mammography for 
breast cancer screening and associations with review 
design and author characteristics. 
No reporting of barriers to screening or interventions to 
improve  
Rainey L.[231] 
 
 
Women's perceptions on personalised risk-based breast 
cancer screening and primary prevention: A systematic 
review. 
Targeted screening (at risk) or diagnostics (symptoms)  
Ravven S.[232] 
 
Cancer treatment for people with mental illness: A 
systematic review of the literature. Cancer treatment and care 
Reames BN[233] 
 
Critical evaluation of oncology clinical practice guidelines. 
[Review] Cancer treatment and care 
Reeves M.M.[234] 
 
Cardiovascular disease incidence and mortality in breast 
cancer survivors compared to the general population: 
Systematic review and meta-analysis. 
Cancer treatment and care 
Reidy M.[235] 
 
 
Cancer screening in women with intellectual disabilities: 
An Irish perspective. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Rezaianzadeh A.[236] 
 
 
The incidence of breast cancer in Iran: A systematic 
review and meta-analysis. 
No reporting of barriers to screening or interventions to 
improve  
Rice L.J.[237] 
 
 
Social Networks Across Common Cancer Types: The 
Evidence, Gaps, and Areas of Potential Impact. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Richardson A.K.[238] 
 
 
Screening for colorectal cancer and prostate cancer: 
Challenges for New Zealand. Non-systematic reviews 
Rivers D.[239] 
 
A systematic review of the factors influencing African 
Americans' participation in cancer clinical trials. Not screening programme related 
Rizer A.M.[240] Challenges in Intervention Research for Lesbian and Bisexual Women. Not screening programme related 
Rogers H.[241] 
 
 
Missed opportunities in the diagnosis of colorectal 
cancer: A mixed methods study and medical records 
review of 252 recently diagnosed patients. 
Other study types (controlled trials, observational 
studies) 
Roland M.[242] Mammotest and breast cancer screening. [French] No reporting of barriers to screening or interventions to improve  
Ronco G.[243] 
 
 
 
[Health technology assessment report: HPV DNA based 
primary screening for cervical cancer precursors]. [Italian] 
No reporting of barriers to screening or interventions to 
improve  
Rubin D.T.[244] 
 
 
Will a 5-ASA a day keep the cancer (and dysplasia) away?. Targeted screening (at risk) or diagnostics (symptoms)  
Runowicz C.D.[245] 
 
 
American cancer society/American society of clinical 
oncology breast cancer survivorship care guideline. Not screening programme related 
Salvador S.[246] 
No. 344-Opportunistic Salpingectomy and Other Methods 
of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal 
Cancer in the General Population. 
Targeted screening (at risk) or diagnostics (symptoms)  
Samuel P.S.[247] 
 
 
 
 
Breast, cervical, and colorectal cancer screening rates 
amongst female Cambodian, Somali, and Vietnamese 
immigrants in the USA. 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Santesso N.[248] 
World Health Organization Guidelines for treatment of 
cervical intraepithelial neoplasia 2-3 and screen-and-treat 
strategies to prevent cervical cancer. 
No reporting of barriers to screening or interventions to 
improve  
Scherr C.L.[249] 
 
 
Genetic counseling for hereditary breast and ovarian 
cancer among Puerto Rican women living in the United 
States. 
Targeted screening (at risk) or diagnostics (symptoms)  
Schiff G.D.[250] 
 
 
Diagnostic pitfalls: A new paradigm to understand and 
prevent diagnostic error. Targeted screening (at risk) or diagnostics (symptoms)  
Schreuders E.H.[251] 
 
 
Colorectal cancer screening: A global overview of existing 
programmes. Non-systematic reviews 
Schreuders, E.H.[252] 
Meta-analysis on guaiac-based fecal occult blood tests 
versus fecal immunochemical tests for colorectal cancer 
screening in average-risk individuals. 
No reporting of barriers to screening or interventions to 
improve 
Sculpher M.J.[253] 
 
 
 
 
Generalisability in economic evaluation studies in 
healthcare: A review and case studies. 
No reporting of barriers to screening or interventions to 
improve  
Senore C.[254] 
 
 
Optimising colorectal cancer screening acceptance: A 
review. Non-systematic reviews 
Sharaf R.[255] 
 
 
Uptake of genetic testing by relatives in Lynch syndrome: 
A systematic review. Targeted screening (at risk) or diagnostics (symptoms)  
Sharaf R.N.[255] 
 
Uptake of Genetic Testing by Relatives of Lynch 
Syndrome Probands: A Systematic Review. Screening for other cancers/diseases 
Sharma P.[256] 
 
 
Advanced imaging in colonoscopy and its impact on 
quality. 
No reporting of barriers to screening or interventions to 
improve  
Sheridan S.L.[257] 
 
 
Shared decision making about screening and 
chemoprevention: A suggested approach from the U.S. 
Preventive Services Task Force. 
Non-systematic reviews 
Sherman K.A.[258] 
 
 
Psychosocial approaches to participation in BRCA1/2 
genetic risk assessment among African American women: 
A systematic review. 
Targeted screening (at risk) or diagnostics (symptoms)  
Shojania K.G.[259] 
 
 
Taking advantage of the explosion of systematic reviews: 
an efficient MEDLINE search strategy. Screening for other cancers/diseases 
Shrivastava S.[260] 
 
Exploring the role of dietary factors in the development 
of breast cancer. Not screening programme related 
Shrivastava S.R.B.[261] 
 
 
Assessing the contribution of dietary factors in breast 
cancer. Cancer treatment and care 
Shuhong W.[262] 
 
 
Cost and cost-effectiveness of digital mammography 
compared with film-screen mammography in Australia. 
No reporting of barriers to screening or interventions to 
improve  
Siebert U.[263] 
 
 
Cost-effectiveness of human papillomavirus testing in 
cervical cancer screening. A review of decision analyses. 
[German] 
No reporting of barriers to screening or interventions to 
improve  
Sigurdsson J.A.[264] 
 
 
Marginal public health gain of screening for colorectal 
cancer: Modelling study, based on WHO and national 
databases in the Nordic countries. 
No reporting of barriers to screening or interventions to 
improve  
Silva N.S.[265] 
Comparison of markov models used for the economic 
evaluation of colorectal cancer screening: A systematic 
review. 
Other study types (controlled trials, observational 
studies) 
Sinaiko A.D.[266] 
 
 
Synthesis of research on patient-centered medical homes 
brings systematic differences into relief. Not screening programme related 
Skirton H.[267] 
 
 
Genomic medicine: What are the challenges for the 
National Health Service?. Targeted screening (at risk) or diagnostics (symptoms)  
Skroumpelos A.[268] 
 
 
Discussing the introduction of national screening 
programs in Greece: A delphi study. 
No reporting of barriers to screening or interventions to 
improve  
Smith J.L.[269] 
 
 
Adaptation of an effective cervical cancer screening 
intervention: Assessing barriers and facilitators to 
screening among Latinas and African American women. 
Non-systematic reviews 
Smith J.S.[270] Cervical cancer and use of hormonal contraceptives: A systematic review. Not screening programme related 
Snowsill T.[271] 
 
 
 
A systematic review and economic evaluation of 
diagnostic strategies for Lynch syndrome. Screening for other cancers/diseases 
Sritharan J.[272] 
 
 
The relationship between modifiable environmental risk 
factors and colorectal cancer: A systematic review. Not screening programme related 
Sritipsukho P.[273] 
 
 
Accuracy of visual inspection with acetic acid (VIA) for 
cervical cancer screening: a systematic review. 
No reporting of barriers to screening or interventions to 
improve  
Stange, Kurt C[274] 
 
In this issue: Many arrows rather than magic bullets. 
[References]. Not screening programme related 
Steinwachs D.[275] 
 
 
 
NIH state-of-the-science conference statement: 
Enhancing use and quality of colorectal cancer screening. Non-systematic reviews 
Stewart A.[276] 
Genetic Testing Strategies in Newly Diagnosed 
Endometrial Cancer Patients Aimed at Reducing 
Morbidity or Mortality from Lynch Syndrome in the Index 
Case or Her Relatives. 
Targeted screening (at risk) or diagnostics (symptoms)  
Stewart D.E.[277] 
 
 
Self-Collected Samples for Testing of Oncogenic Human 
Papillomavirus: A Systematic Review. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Stromsvik N[278] 
 
Men in the women's world of hereditary breast and 
ovarian cancer--a systematic review. Targeted screening (at risk) or diagnostics (symptoms)  
Stuart G.[279] 
 
 
Report of the 2003 Pan-Canadian Forum on Cervical 
Cancer Prevention and Control. The recommendations 
reported herein reflect the decisions of the pan-Canadian 
forum participants as individual experts and do not 
No reporting of barriers to screening or interventions to 
improve  
necessarily reffect official policies of their respective 
organizations. 
Sullivan W.[280] 
 
 
Developing national guidance on genetic testing for 
breast cancer predisposition: The role of economic 
evidence?. 
Targeted screening (at risk) or diagnostics (symptoms)  
Sutherland J.[281] 
 
 
All-cause 30-day postoperative mortality for older 
patients in developed countries presenting for elective 
colorectal surgery: A systematic review protocol. 
Cancer treatment and care 
Tappenden P.[282] 
 
Whole disease modeling to inform resource allocation 
decisions in cancer: A methodological framework. 
No reporting of barriers to screening or interventions to 
improve  
Tavakolpour S.[283] 
 
Hepatitis B reactivation during immunosuppressive 
therapy or cancer chemotherapy, management, and 
prevention: A comprehensive review-screened. 
Screening for other cancers/diseases 
Tepper N.K.[284] 
 
 
Laboratory screening prior to initiating contraception: A 
systematic review. Targeted screening (at risk) or diagnostics (symptoms)  
Tiwari A.K.[285] 
 
 
Progress against cancer (1971-2011): How far have we 
come?. Non-systematic reviews 
Towler B.P.[286] 
 
 
Screening for colorectal cancer using the faecal occult 
blood test, hemoccult. 
No reporting of barriers to screening or interventions to 
improve  
Tsu V.[287] 
 
 
Human papillomavirus vaccination in low-resource 
countries: Lack of evidence to support vaccinating 
sexually active women. 
Not screening programme related 
Tuffaha H.W.[288] 
 
 
Value of information analysis in oncology: The value of 
evidence and evidence of value. Not screening programme related 
van der Heide I.[289] 
 
Health literacy and informed decision making regarding 
colorectal cancer screening: a systematic review. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Van Herwaarden Y.J.[290] 
 
. 
Low prevalence of serrated polyposis syndrome in 
screening populations: A systematic review. 
No reporting of barriers to screening or interventions to 
improve  
Vasilevska M.[291] 
 
 
Relative risk of cervical cancer in indigenous women in 
Australia, Canada, New Zealand, and the United States: A 
systematic review and meta-analysis. 
No reporting of barriers to screening or interventions to 
improve  
Vetto, John T[292] Teaching Breast Self-Examination: A Tale of Two Cities. [References]. Not screening programme related 
Vinnicombe S.[293] 
 
 
 
Full-field digital versus screen-film mammography: 
Comparison within the UK breast screening program and 
systematic review of published data. 
No reporting of barriers to screening or interventions to 
improve  
Vourlekis B.[294] 
 
 
Evidence-based assessment in case management to 
improve abnormal cancer screen follow-up. 
 
Non-systematic reviews 
 
Wang S[295] 
 
 
Cost and cost-effectiveness of digital mammography 
compared with film-screen mammography in Australia. 
[Review] [18 refs] 
No reporting of barriers to screening or interventions to 
improve  
Watine J.C.[296] 
 
 
Mass colorectal cancer screening: Methodological quality 
of practice guidelines is not related to their content 
validity. 
No reporting of barriers to screening or interventions to 
improve  
Weinstein L.C.[297] 
 
 
Cancer screening, prevention, and treatment in people 
with mental illness. Non-systematic reviews 
Weiss J.E.[298] 
 
 
 
Challenges With Identifying Indication for Examination in 
Breast Imaging as a Key Clinical Attribute in Practice, 
Research, and Policy. 
No reporting of barriers to screening or interventions to 
improve  
Wells K.J.[299] 
 
 
Patient navigation: State of the art or is it science?. Non-systematic reviews 
Whitlock E.P.[300] 
 
Screening for colorectal cancer: A targeted, updated 
systematic review for the U.S. Preventive Services Task 
Force. 
No reporting of barriers to screening or interventions to 
improve  
Whitlock E.P.[301] 
 
 
Liquid-based cytology and human papillomavirus testing 
to screen for cervical cancer: a systematic review for the 
U.S. Preventive Services Task Force. 
No reporting of barriers to screening or interventions to 
improve  
Whop L.[302] 
 
 
Navigating the cancer journey: A review of patient 
navigator programs for indigenous cancer patients. Cancer treatment and care 
Wille-Jorgensen P[303] 
 
 
Systematic reviews and meta-analyses in coloproctology: 
interpretation and potential pitfalls. [Review] [75 refs] 
No reporting of barriers to screening or interventions to 
improve  
Wollins D.S.[304] 
 
 
Q and A: Magnetic resonace imaging in the detection and 
evaluation of breast cancer. Not screening programme related 
Wong V.S.W.[305] 
 
 
Effectiveness of colorectal cancer preventive measures 
among ethnic minorities-an integrative review. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Wood B.[306] 
 
 
Eliciting women's cervical screening preferences: A mixed 
methods systematic review protocol. Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Wortley S[307] 
 
 
What is the role of community preference information in 
health technology assessment decision making? A case 
study of colorectal cancer screening. 
No reporting of barriers to screening or interventions to 
improve  
Zapka J.[308] 
 
Factors in quality care-the case of follow-up to abnormal 
cancer screening tests-problems in the steps and 
interfaces of care. 
Non-systematic reviews 
Zapka J.M.[309] 
 
 
Follow-up to abnormal cancer screening tests: 
Considering the multilevel context of care. Not screening programme related 
Zhang H.[310] 
Temporal trends, incidence, and prevalence of young-
onset colorectal cancer: A systematic review and meta-
analysis. 
Cancer treatment and care 
Zhang Z.[311] 
 
 
Individualized management of pregnant women with 
high hepatitis B virus DNA levels. Screening for other cancers/diseases 
Zhao F.-H.[312] 
 
 
 
. 
Pooled analysis of a self-sampling HPV DNA test as a 
cervical cancer primary screening method. 
No reporting of barriers to screening or interventions to 
improve  
Zwahlen M.[313] 
 
Mammography screening in Switzerland: Limited 
evidence from limited data. Non-systematic reviews 
Duplicates not excluded electronically due to differences in records (main authors: Escoffrey, Dhana, Lewis, Hewitson, Ilic, Karnon, Pron, Chamot).   
 
Web of Science – studies excluded based on title/abstract 
First Author Title Reasons for Exclusion 1 
Abdullahi, Leila H.[314] 
Knowledge, attitudes and practices on adolescent 
vaccination among adolescents, parents and teachers in 
Africa: A systematic review 
Not screening programme related 
Akar, S. Z.[315] The Role of Cultural Factors in Mammography Screening: Systematic Review Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Balmer, Claire[316] 
A qualitative systematic review exploring lay 
understanding of cancer by adults without a cancer 
diagnosis 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Belkic, Karen[317] 
Imaging surveillance programs for women at high breast 
cancer risk in Europe: Are women from ethnic minority 
groups adequately included? 
Targeted screening (at risk) or diagnostics (symptoms)  
Boger, Emma[318] 
Self-Management and Self-Management Support 
Outcomes: A Systematic Review and Mixed Research 
Synthesis of Stakeholder Views 
Cancer treatment and care 
Braat, Manon N. G. J. 
A.[319] 
Radioembolization-induced liver disease: a systematic 
review Screening for other cancers/diseases 
Brigic, Adela[320] 
A systematic review regarding the feasibility and safety of 
endoscopic full thickness resection (EFTR) for colonic 
lesions 
Cancer treatment and care 
Ciria, Ruben[321] Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing Cancer treatment and care 
Comino, Elizabeth 
Jean[322] 
A systematic review of interventions to enhance access 
to best practice primary health care for chronic disease 
management, prevention and episodic care 
 Not screening programme related 
El-Kareh, Robert[323] Use of health information technology to reduce diagnostic errors Targeted screening (at risk) or diagnostics (symptoms)  
Fone, D[324] 
Systematic review of the use and value of computer 
simulation modelling in population health and health 
care delivery 
No reporting of barriers to screening or interventions to 
improve  
Fowler, Robert A.[325] 
An Official American Thoracic Society Systematic Review: 
The Association between Health Insurance Status and 
Access, Care Delivery, and Outcomes for Patients Who 
Are Critically III 
Not screening programme related 
Franco, EL; [326] Evidence-based policy recommendations on cancer screening and prevention 
No reporting of barriers to screening or interventions to 
improve  
Goossens, Joline[327] 
Cancer patients' and professional caregivers' needs, 
preferences and factors associated with receiving and 
providing fertility-related information: A mixed-methods 
systematic review 
Cancer treatment and care 
Graetz, V.[328] Utilization of health care services by migrants in Europe-a systematic literature review 
No reporting of barriers to screening or interventions to 
improve  
Green, BB[329] Breast cancer screening controversies No reporting of barriers to screening or interventions to improve  
Greenwald, Peter[330] 
 
Do We Make Optimal Use of the Potential of Cancer 
Prevention? Not screening programme related 
Greer, Joseph A.[331] 
 
A Systematic Review of Adherence to Oral Antineoplastic 
Therapies Cancer treatment and care 
Guirguis-Blake, Janelle 
M.[332] 
Periodic Screening Pelvic Examination Evidence Report 
and Systematic Review for the US Preventive Services 
Task Force 
No reporting of barriers to screening or interventions to 
improve  
Herrmann, Anne[333] 
Wilfully out of sight? A literature review on the 
effectiveness of cancer-related decision aids and 
implementation strategies 
Non-systematic reviews 
Hoffmann, Tammy 
C.[334] 
Patients' Expectations of the Benefits and Harms of 
Treatments, Screening, and Tests A Systematic Review Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Howell, Doris[335] 
A Pan-Canadian practice guideline: prevention, screening, 
assessment, and treatment of sleep disturbances in 
adults with cancer 
Cancer treatment and care 
Hurtado-de-Mendoza, 
Alejandra[336] 
Behavioral Interventions to Enhance Adherence to 
Hormone Therapy in Breast Cancer Survivors: A 
Systematic Literature Review 
Cancer treatment and care 
Janberidze, Elene[337] 
How Are Patient Populations Characterized in Studies 
Investigating Depression in Advanced Cancer? Results 
From a Systematic Literature Review 
Cancer treatment and care 
Johnson, Wendy A.[338] 
 
Intimate Partner Violence Among Women Diagnosed 
With Cancer Cancer treatment and care 
Kim, Kyounghae[339] 
Effects of Community-Based Health Worker Interventions 
to Improve Chronic Disease Management and Care 
Among Vulnerable Populations: A Systematic Review 
No reporting of barriers to screening or interventions to 
improve  
Kyrgiou, Maria[340] Adiposity and cancer at major anatomical sites: umbrella review of the literature 
No reporting of barriers to screening or interventions to 
improve  
Lawrence, Renae A.[341] Primary Care Physicians' Perspectives of Their Role in Cancer Care: A Systematic Review Cancer treatment and care 
Luzak, Agnes[342] Clinical effectiveness of cancer screening biomarker tests offered as self-pay health service: a systematic review 
No reporting of barriers to screening or interventions to 
improve  
Macefield, Rhiannon 
C.[343] 
A systematic review of on-site monitoring methods for 
health-care randomised controlled trials Not screening programme related 
McCready, T[344] Breast self-examination and breast awareness: a literature review Not screening programme related 
Meiklejohn, Judith 
A.[345] 
The role of the GP in follow-up cancer care: a systematic 
literature review Cancer treatment and care 
Miovic, Michael[346] Psychiatric disorders in advanced cancer Cancer treatment and care 
Nerich, Virginie[347] Cost-utility analyses of drug therapies in breast cancer: a systematic review Cancer treatment and care 
Noble, Meredith[348] Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis 
No reporting of barriers to screening or interventions to 
improve  
Oeffinger, Kevin C.[349] Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society 
No reporting of barriers to screening or interventions to 
improve  
Otte, Julie L.[350] Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained? Cancer treatment and care 
Patel, SA[351] Outcomes in older people undergoing operative intervention for colorectal cancer Cancer treatment and care 
Pearson, Sallie-Anne[352] 
Studies using Australia's Pharmaceutical Benefits Scheme 
data for pharmacoepidemiological research: a systematic 
review of the published literature (1987-2013) 
Not screening programme related 
Pirrone, Federica[353] Olfactory detection of cancer by trained sniffer dogs: A systematic review of the literature Not screening programme related 
Powe, BD; Finnie, R[354] Cancer fatalism - The state of the science Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Reynolds, Lisa M.[355] 
Disgust and Behavioral Avoidance in Colorectal Cancer 
Screening and Treatment A Systematic Review and 
Research Agenda 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Roine, Eija[356] 
Cost-effectiveness of interventions based on physical 
exercise in the treatment of various diseases: A 
systematic literature review 
Cancer treatment and care 
Rutter, Matthew D.[357] 
British Society of Gastroenterology/Association of 
Coloproctologists of Great Britain and Ireland guidelines 
for the management of large non-pedunculated 
colorectal polyps 
Cancer treatment and care 
Senore, Carlo[358] 
 Organization of surveillance in GI practice  Not screening programme related 
Shan, Lianfeng[359] 
PCR-Based Assays versus Direct Sequencing for 
Evaluating the Effect of KRAS Status on Anti-EGFR 
Treatment Response in Colorectal Cancer Patients: A 
Systematic Review and Meta-Analysis 
Not screening programme related 
Shepherd, J. P.[360] Interventions for encouraging sexual behaviours intended to prevent cervical cancer Not screening programme related 
Singal, Amit G.[361] 
Early Detection, Curative Treatment, and Survival Rates 
for Hepatocellular Carcinoma Surveillance in Patients 
with Cirrhosis: A Meta-analysis 
Screening for other cancers/diseases 
Stock, Christian[362] 
Population-based prevalence estimates of history of 
colonoscopy or sigmoidoscopy: review and analysis of 
recent trends 
Targeted screening (at risk) or diagnostics (symptoms)  
Subnis, Utkarsh B.[363] 
Psychosocial Therapies for Patients With Cancer: A 
Current Review of Interventions Using 
Psychoneuroimmunology-Based Outcome Measures 
Cancer treatment and care 
Tapia-Siles, Silvia C.[364] 
Current state of micro-robots/devices as substitutes for 
screening colonoscopy: assessment based on technology 
readiness levels 
No reporting of barriers to screening or interventions to 
improve  
Tricco, Andrea C.[365] 
Canadian oncogenic human papillomavirus cervical 
infection prevalence: Systematic review and meta-
analysis 
No reporting of barriers to screening or interventions to 
improve  
van den Beuken-van 
Everdingen, Marieke H. 
J.[366] 
Update on Prevalence of Pain in Patients With Cancer: 
Systematic Review and Meta-Analysis Cancer treatment and care 
Vermeulen, V[367] 
Impact of health technology assessment on preventive 
screening in Belgium - Case studies of mammography in 
breast cancer, PSA screening in prostate cancer, and 
ultrasound in normal pregnancy 
 Non-systematic reviews 
Wade, R.[368] 
Adjunctive colposcopy technologies for examination of 
the uterine cervix - DySIS, LuViva Advanced Cervical Scan 
and Niris Imaging System: a systematic review and 
economic evaluation 
No reporting of barriers to screening or interventions to 
improve  
Wainberg, S[369] Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation Targeted screening (at risk) or diagnostics (symptoms)  
Wentzensen, Nicolas[370] Early Detection of Cervical Carcinomas Finding an Overall Approach 
No reporting of barriers to screening or interventions to 
improve  
Wigle, Jannah[371] 
Human papillomavirus (HPV) vaccine implementation in 
low and middle-income countries (LMICs): Health system 
experiences and prospects 
Not screening programme related 
Wong, Carlos K. H.[372] 
Possible Impact of Incremental Cost-Effectiveness Ratio 
(ICER) on Decision Making for Cancer Screening in Hong 
Kong: A Systematic Review 
No reporting of barriers to screening or interventions to 
improve  
Zapka, JG[373] A framework for improving the quality of cancer care: The case of breast and cervical cancer screening Non-systematic reviews 
 Cochrane Reviews 
First Author Title  Reason for exclusion 
Gøtzsche, P [374] Screening for breast cancer with mammography 
No reporting of barriers to screening or interventions to 
improve  
Gartlehner, G[375] 
Mammography in combination with breast 
ultrasonography versus mammography for breast cancer 
screening in women at average risk 
No reporting of barriers to screening or interventions to 
improve  
Ilic, D[135]DUPLICATE Screening for prostate cancer Screening for other cancers/diseases 
Holme, O[376] 
Flexible sigmoidoscopy versus faecal occult blood testing 
for colorectal cancer screening in asymptomatic 
individuals 
No reporting of barriers to screening or interventions to 
improve  
Kösters, PJ[377] TI: Regular self-examination or clinical examination for early detection of breast cancer 
Not screening programme related 
Posadzki, P[378] 
TI: Automated telephone communication systems for 
preventive healthcare and management of long-term 
conditions 
 No reporting of barriers to screening or interventions to 
improve 
Miller, D[379] TI: Interventions for relieving the pain and discomfort of screening mammography 
No reporting of barriers to screening or interventions to 
improve  
Hilgart, JS[380] TI: Cancer genetic risk assessment for individuals at risk of familial breast cancer 
Targeted screening (at risk) or diagnostics (symptoms)  
Hafner, S[381] TI: Water infusion versus air insufflation for colonoscopy 
No reporting of barriers to screening or interventions to 
improve  
Kyrgiou, M[382] 
TI: Immediate referral to colposcopy versus cytological 
surveillance for minor cervical cytological abnormalities 
in the absence of HPV test 
Cancer treatment and care 
Grabosch, SM[383] 
TI: Non-steroidal anti-inflammatory agents to induce 
regression and prevent the progression of cervical 
intraepithelial neoplasia 
Cancer treatment and care 
Brockbank, E[384] TI: Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer 
Cancer treatment and care 
Cruickshank, S[385] TI: Specialist breast care nurses for supportive care of women with breast cancer 
Cancer treatment and care 
Goodwin, A[386] TI: Post-operative radiotherapy for ductal carcinoma in situ of the breast 
Cancer treatment and care 
Galaal, K[387] TI: Interventions for reducing anxiety in women undergoing colposcopy 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
Rydzewska, L[388] TI: Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer 
Cancer treatment and care 
Scatchard, K[389] TI: Chemotherapy for metastatic and recurrent cervical cancer 
Cancer treatment and care 
Arbyn, M[390] TI: Low cost versus other screening tests to detect cervical cancer or precancer in developing countries 
No reporting of barriers to screening or interventions to 
improve  
van der Heijden, E[391] 
TI: Follow-up strategies after treatment (large loop 
excision of the transformation zone (LLETZ)) for cervical 
intraepithelial neoplasia (CIN): Impact of human 
papillomavirus (HPV) test 
Cancer treatment and care 
Staley, H[392] TI: Postoperative tamoxifen for ductal carcinoma in situ Cancer treatment and care 
Mao, C[393] TI: Toremifene versus tamoxifen for advanced breast cancer 
Cancer treatment and care 
Moschetti, I[394] TI: Follow-up strategies for women treated for early breast cancer 
Cancer treatment and care 
Martin-Hirsch, PPL[395] TI: Collection devices for obtaining cervical cytology samples 
No reporting of barriers to screening or interventions to 
improve  
Van Roon, AHC[396] 
TI: Guaiac-based faecal occult blood tests versus faecal 
immunochemical tests for colorectal cancer screening in 
average-risk individuals 
No reporting of barriers to screening or interventions to 
improve  
Flight, IHK[397] 
TI: Interventions for improving uptake of population-
based screening for colorectal cancer using fecal occult 
blood testing 
 No reporting of barriers to screening or interventions to 
improve – PROTOCOL ONLY 
Khan, SM[398] TI: Wound drainage after plastic and reconstructive surgery of the breast 
Cancer treatment and care 
Brown, SR[399] TI: Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum 
Targeted screening (at risk) or diagnostics (symptoms)  
Skoetz, N[400] 
TI: Prophylactic antibiotics or G(M)-CSF for the 
prevention of infections and improvement of survival in 
cancer patients receiving myelotoxic chemotherapy 
Cancer treatment and care 
Singh, H[401] TI: Propofol for sedation during colonoscopy Not screening programme related 
Koliopoulos, G[402] TI: Cytology versus HPV testing for cervical cancer screening in the general population 
No reporting of barriers to screening or interventions to 
improve  
Phillips, J[403] 
TI: Screening sigmoidoscopy and colonoscopy for 
reducing colorectal cancer mortality in asymptomatic 
persons 
 No reporting of barriers to screening or interventions to 
improve 
Gillies, K[404] TI: Decision aids for people considering taking part in clinical trials 
Not screening programme related 
Cavalheri, V[405] TI: Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer 
Screening for other cancers/diseases 
Hurlow, A[406] TI: Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults 
Cancer treatment and care 
Morgan, J[407] TI: Transparent Cap Colonoscopy versus Standard Colonoscopy to Improve Caecal Intubation 
No reporting of barriers to screening or interventions to 
improve  
Dobbins, M[408] 
TI: School-based physical activity programs for promoting 
physical activity and fitness in children and adolescents 
aged 6 to 18 
Not screening programme related 
Macaya, A[409] TI: Interventions for anal canal intraepithelial neoplasia Screening for other cancers/diseases 
Rollason, V[410] TI: Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ) 
Screening for other cancers/diseases 
Birch, DW[411] TI: Heated insufflation with or without humidification for laparoscopic abdominal surgery 
Screening for other cancers/diseases 
Mosli, MH[412] TI: Histologic scoring indices for evaluation of disease activity in ulcerative colitis 
Screening for other cancers/diseases 
O’Mahoney, M[413] TI: Interventions for raising breast cancer awareness in women 
Personal and cultural barriers (e.g. attitudes, beliefs, fear) 
 
Studies excluded based on full text review 
 First Author  Reason for exclusion 
Abdel-Aleem[1]  Mobile clinics for women's and children's health No barriers or facilitators 
Altobelli E.[414] 
Breast cancer screening programmes across the WHO 
European region: Differences among countries based on 
national income level. 
No barriers or facilitators 
Andresen[415] 
Pap, Mammography, and Clinical Breast Examination 
Screening Among Women with Disabilities: A Systematic 
Review 
No barriers or facilitators 
Anonymous[416] Recommendations on screening for breast cancer in average-risk women aged 40-74 years. No barriers or facilitators 
Anonymous[417] Abstracts of the British Psychosocial Oncology Society 2016 Annual Conference. No barriers or facilitators 
Asonganyi E.[418] 
Factors affecting compliance with clinical practice 
guidelines for pap smear screening among healthcare 
providers in africa: systematic review and meta-
summary of 2045 individuals. [Review] 
Duplicate or secondary publication 
Babu G.R.[419] Epidemiological correlates of breast cancer in South India. No barriers or facilitators 
Baron R.C.[420] 
Client-Directed Interventions to Increase Community 
Demand for Breast, Cervical, and Colorectal Cancer 
Screening. A Systematic Review. 
Duplicate or secondary publication 
Blackwell S.C.[421] Enough evidence to treat? The American College of Obstetricians and Gynecologists Guidelines. Not systematic review 
Brocklehurst[422] Screening programmes for the early detection and prevention of oral cancer Other - Not correct cancer type 
Bromley E.G.[423] 
A systematic review of patient, provider, and system 
barriers to colorectal cancer screening with colonoscopy 
in african-americans. 
Duplicate or secondary publication 
Brouwers M.C.[424] What implementation interventions increase cancer screening rates? a systematic review. Other - Cited SR in other publication 
Devaney[425] Navigating healthcare: gateways to cancer screening Not systematic review 
Dieng [72] Screening programmes for the early detection and prevention of oral cancer Other - Risk population 
Donnelly[426] Arab Women's Breast Cancer Screening Practices: A Literature Review Not systematic review 
Falk[427] A systematic review of legislation impacting breast and cervical cancer prevention interventions in Texas. Not systematic review 
Flight,[397] 
Interventions for improving uptake of population-based 
screening for colorectal cancer using fecal occult blood 
testing 
No barriers or facilitators - PROTOCOL ONLY 
Francis[428] Cochrane Collaboration and Systematic Reviews  - Age and Ageing Personal and cultural 
Haddock[429] Clinic capacity and spatial access to preventive breast health services for underserved survivors across texas. No barriers or facilitators 
Holden, DJ[430] Enhancing the use and quality of colorectal cancer screening Duplicate or secondary publication 
Honein-AbouHaidar 
G.N.[431] 
Benefits and barriers to participation in colorectal 
cancer screening: A protocol for a systematic review and 
synthesis of qualitative studies. 
No barriers or facilitators 
Honein-AbouHaidar 
G.N.[431] 
Benefits and barriers to participation in colorectal 
cancer screening: A protocol for a systematic review and 
synthesis of qualitative studies. 
No barriers or facilitators 
Ko, M[432] Colorectal cancer screening behaviors among Korean Americans. Not systematic review 
Linsky, A[433] 
Capsule Commentary on Genoff et al., Navigating 
Language Barriers: A Systematic Review of Patient 
Navigators' Impact on Cancer Screening for Limited 
English Proficient Patients. 
Not systematic review 
Lionis, C[434] 
Colorectal cancer screening and the challenging role of 
general practitioner/family physician: An issue of 
quality. 
Not systematic review 
McLachlan S.[435] Patients' experiences and reported barriers to screening colonoscopy: A systematic review. Duplicate or secondary publication 
Mema[436] Integrated cancer screening performance indicators: A systematic review. No barriers or facilitators 
Mitchell, AJ[437] 
Breast cancer screening in women with mental illness: 
comparative meta-analysis of mammography uptake. 
[Review] 
No barriers or facilitators 
Rossi P.G.[438]  [Methods to increase participation in cancer screening programmes]. [Italian] Duplicate or secondary publication 
Sabatino[439] 
Interventions to Increase Recommendation and Delivery 
of Screening for Breast, Cervical, and Colorectal Cancers 
by Healthcare Providers. Systematic Reviews of Provider 
Assessment and Feedback and Provider Incentives. 
Not systematic review 
Saitz[440] 
'We do not see the lens through which we look': 
Screening mammography evidence and non-financial 
conflicts of interest. 
Not systematic review 
Sarai Racey C.[441] 
Self-collected HPV testing improves participation in 
cervical cancer screening: A systematic review and 
meta-analysis. 
Duplicate or secondary publication 
Smith, AA[442] 
Advanced practice registered nurses, physician 
assistants and cancer prevention and screening: a 
systematic review. 
No barriers or facilitators 
Vernon[443] Interventions to promote repeat breast cancer screening with mammography No barriers or facilitators 
Viswanathan,  M[444] Outcomes of community health worker interventions. Duplicate or secondary publication 
Whop[302] A systematic review of patient navigator programs for indigenous cancer patients. Not systematic review 
Yabroff, KR[445] 
Advancing comparative studies of patterns of care and 
economic outcomes in cancer: Challenges and 
opportunities. 
No barriers or facilitators 
Zapka [309]  Follow up to abnormal cancer screening tests Duplicate or secondary publication 
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AMSTAR – a measurement tool to assess the methodological quality of systematic reviews. 
1. Was an 'a priori' design provided? 
The research question and inclusion criteria should be established before the conduct of the review.   
 
2. Was there duplicate study selection and data extraction? 
There should be at least two independent data extractors and a consensus procedure for 
disagreements should be in place. 
 
3. Was a comprehensive literature search performed? 
At least two electronic sources should be searched. The report must include years and databases 
used (e.g., Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and 
where feasible the search strategy should be provided. All searches should be supplemented by 
consulting current contents, reviews, textbooks, specialized registers, or experts in the particular 
field of study, and by reviewing the references in the studies found. 
 
4. Was the status of publication (i.e. grey literature) used as an inclusion criterion? 
The authors should state that they searched for reports regardless of their publication type. The 
authors should state whether or not they excluded any reports (from the systematic review), based 
on their publication status, language etc. 
 
5. Was a list of studies (included and excluded) provided? 
A list of included and excluded studies should be provided. 
 
6. Were the characteristics of the included studies provided? 
In an aggregated form such as a table, data from the original studies should be provided on the 
participants, interventions and outcomes. The ranges of characteristics in all the studies analyzed 
e.g., age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases 
should be reported. 
 
7. Was the scientific quality of the included studies assessed and documented? 
'A priori' methods of assessment should be provided (e.g., for effectiveness studies if the author(s) 
chose to include only randomized, double-blind, placebo controlled studies, or allocation 
concealment as inclusion criteria); for other types of studies alternative items will be relevant. 
 
8. Was the scientific quality of the included studies used appropriately in formulating conclusions? 
The results of the methodological rigor and scientific quality should be considered in the analysis and 
the conclusions of the review, and explicitly stated in formulating recommendations. 
 
9. Were the methods used to combine the findings of studies appropriate? 
For the pooled results, a test should be done to ensure the studies were combinable, to assess their 
homogeneity (i.e., Chi-squared test for homogeneity, I2). If heterogeneity exists a random effects 
model should be used and/or the clinical appropriateness of combining should be taken into 
consideration (i.e., is it sensible to combine?). 
 
10. Was the likelihood of publication bias assessed? 
An assessment of publication bias should include a combination of graphical aids (e.g., funnel plot, 
other available tests) and/or statistical tests (e.g., Egger regression test, Hedges-Olken). 
 
11. Was the conflict of interest included? 
Potential sources of support should be clearly acknowledged in both the systematic review and the 
included studies. 
 
Answer scale for all questions: 
□ Yes 
□ No 
□ Can't answer 
□ Not applicable 
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